{"content":"<li class=\"n-box-item date-title\" data-end=\"1501041599\" data-start=\"1500955200\" data-txt=\"Monday, December 23, 2019\">Tuesday, July 25, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3281237\" data-ts=\"1501032176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281237-steve-wynn-talks-long-game-in-macau\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steve Wynn talks the long game in Macau</a></h4><ul>     <li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>)&nbsp;<font color='red'>fell 3.76%</font>&nbsp;in AH trading as the <a href=\"https://seekingalpha.com/news/3281108-wynn-resorts-beats-0_04-beats-revenue\" target=\"_blank\">bottom line</a> from the company's Wynn Palace propery disappointed. The Macau casino brought in property earnings of $87.4M vs. $116M expected. During the earnings call, CEO Steve Wynn said light rail construction was a \"severe\" handicap on mass market traffic and other construction nearly has the casino boxed in temporarily.</li>          <li><a href=\"https://lasvegassun.com/news/2017/jul/25/wynn-says-he-has-most-precious-piece-of-real-estat/\" target=\"_blank\">Results</a> at the Wynn Macau property were also a bit light during the quarter, due in part to Lady Luck, according to Steve Wynn. \"At Wynn Macau, we had a most unique statistical anomaly, one that I&rsquo;ve never seen in my 50 years doing this,&rdquo; he noted. &ldquo;Even with enormous volume, one of our leading outlets lost money for an entire month ... In April the bottom fell out and all the players won millions of dollars.\"</li><li>Wynn also hit on one of his favorite conference call themes, chiding analysts for focusing on the quarterly results when the long-term strategy is on track. His big takeway from Macau is that cannibalization hasn't been an issue despite the casino operator's growth in the region.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3281237\" data-linked=\"Steve Wynn talks the long game in Macau\" data-tweet=\"$WYNN - Steve Wynn talks the long game in Macau https://seekingalpha.com/news/3281237-steve-wynn-talks-long-game-in-macau?source=tweet\" data-url=\"https://seekingalpha.com/news/3281237-steve-wynn-talks-long-game-in-macau\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281235\" data-ts=\"1501025652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281235-new-caesars-gets-shareholder-approvals-for-restructuring\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Caesars gets shareholder approvals for restructuring</a></h4><ul>   <li>Caesars Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a>) and Caesars Acquisition Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CACQ' title='Caesars Acquisition Company'>CACQ</a>) have gotten their respective shareholders' <a href=\"https://seekingalpha.com/pr/16896280-caesars-entertainment-corporation-caesars-acquisition-company-announce-stockholder-approval\" target=\"_blank\">approvals to merge together</a>, a key step in the reorganization.</li>    <li><a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> is <font color='green'>up 2.3%</font> after hours.</li>    <li>Caesars shareholders gave 87.8% approval, and CAC shareholders approved with 95.2% in favor.</li>    <li>The two have gotten approvals from several jurisdictions where they operate and are engaging with regulators in the remaining ones. They expect to complete the merger in the first week of October.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3278797-new-caesars-gets-approvals-new-jersey\" target=\"_blank\">New Caesars gets approvals in New Jersey</a> (Jul. 14 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281235\" data-linked=\"New Caesars gets shareholder approvals for restructuring\" data-tweet=\"$CZR $CZR $CACQ - New Caesars gets shareholder approvals for restructuring https://seekingalpha.com/news/3281235-new-caesars-gets-shareholder-approvals-for-restructuring?source=tweet\" data-url=\"https://seekingalpha.com/news/3281235-new-caesars-gets-shareholder-approvals-for-restructuring\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281233\" data-ts=\"1501024688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281233-form-holdings-sets-stock-offering-to-fund-xpresspa-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FORM Holdings sets stock offering to fund XpresSpa expansion</a></h4><ul>   <li>FORM Holdings (<a href=\"http://seekingalpha.com/symbol/FH\" target=\"_blank\">FH</a> <font color='red'>-8.1%</font>) says it plans to sell shares in a <a href=\"https://seekingalpha.com/pr/16896311-form-holdings-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a>.</li>    <li>The company is selling all the shares in the offering. Underwriters will get an option to buy up to an additional 15% of the common shares on offer. No other terms were disclosed.</li>    <li>It plans to use proceed for capex related to opening new locations of its XpresSpa and for general purposes.</li>    <li>Roth Capital Partners is the offering's sole manager.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281233\" data-linked=\"FORM Holdings sets stock offering to fund XpresSpa expansion\" data-tweet=\"$XSPA - FORM Holdings sets stock offering to fund XpresSpa expansion https://seekingalpha.com/news/3281233-form-holdings-sets-stock-offering-to-fund-xpresspa-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3281233-form-holdings-sets-stock-offering-to-fund-xpresspa-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281223\" data-ts=\"1501019911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281223-t-q2-prepaid-boosts-phone-subscribers-slowing-postpaid-declines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T Q2: Prepaid boosts phone subscribers; slowing postpaid declines</a></h4><ul>     <li>Digging more into AT&amp;T's (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) operational results (<a href=\"https://seekingalpha.com/article/4090429-t-inc-2017-q2-results-earnings-call-slides\" target=\"_blank\">slides here</a>), the company's 178,000 branded phone net additions were powered by 267,000 prepaid adds.</li>     <li>That meant a decline in postpaid phones of 89,000 subs -- a Y/Y improvement in those declines, for the fifth straight quarter (and as mentioned, best-ever postpaid phone churn of 0.79%).</li>     <li>Postpaid phone subs came to 64.6M at quarter's end.</li>     <li>AT&amp;T shares are now <font color='green'>up 2.5%</font> after hours.</li>     <li>The 476,000 wireless net adds in Mexico brought the company to 13.1M total subscribers there. AT&amp;T has more than 88M LTE POPs, which covers 74% of the population.</li>     <li>In video, AT&amp;T lost about 351,000 traditional video subscribers (156,000 DirecTV, 195,000 U-verse) and added 152,000 DirecTV Now subs in a bit of a rebound there, bringing the streaming service's total to about 500,000.</li>     <li>AT&amp;T added it expects its $85B acquisition of Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) to close by the end of the year. Recent reports suggest a long review by the government is <a href=\"https://seekingalpha.com/news/3280572-bloomberg-t-time-warner-talking-merger-terms-u-s\" target=\"_blank\">heading into final stages</a>.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3281110-t-plus-1_9-percent-profits-beat-company-adds-wireless-subs\" target=\"_blank\">AT&amp;T +1.9% as profits beat, company adds wireless subs</a> (Jul. 25 2017)</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3281080-amp-t-beats-0_05-revenue-line\" target=\"_blank\">AT&amp;T beats by $0.05,  revenue in-line</a> (Jul. 25 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281223\" data-linked=\"AT&amp;T Q2: Prepaid boosts phone subscribers; slowing postpaid declines\" data-tweet=\"$T $T $TWX - AT&amp;T Q2: Prepaid boosts phone subscribers; slowing postpaid declines https://seekingalpha.com/news/3281223-t-q2-prepaid-boosts-phone-subscribers-slowing-postpaid-declines?source=tweet\" data-url=\"https://seekingalpha.com/news/3281223-t-q2-prepaid-boosts-phone-subscribers-slowing-postpaid-declines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281217\" data-ts=\"1501018562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281217-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='green'>+25.1%</font>. <a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a> <font color='green'>+22.3%</font>. <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+9.1%</font>. <a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='green'>+3.2%</font>. <a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='green'>+2.7%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/USNA' title='USANA Health Sciences Inc.'>USNA</a> <font color='red'>-14.4%</font>. <a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a> <font color='red'>-10.9%</font>. <a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a> <font color='red'>-7.2%</font>. <a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='red'>-6.4%</font>. <a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='red'>-3.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281217\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$IRBT $TTPH $X - After Hours Gainers / Losers https://seekingalpha.com/news/3281217-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3281217-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281216\" data-ts=\"1501018516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281216-akamai-beats-q2-estimates-shows-game-download-weakness-shares-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akamai beats Q2 estimates, shows game download weakness; shares down 7%</a></h4><ul><li>        Akamai Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) announces Q2 results with beats on revenue and EPS, but investors were still wary from the company&rsquo;s prior guidance lowering for the quarter due to weak game downloads. &nbsp;</li><li>        Customer revenue by division: Web revenue was&nbsp;<font color='green'>up 15%</font>&nbsp;on the year to $315M, Media revenue was&nbsp;<font color='red'>down 2%</font>&nbsp;to $276M, and Enterprise and Carrier sales were&nbsp;<font color='green'>up 9%</font>&nbsp;to $18M.</li><li>               Revenue by solution categories: Performance and Security&nbsp;<font color='green'>up 15%</font>&nbsp;to $376M with $115M of that coming from Cloud Security,&nbsp;<font color='green'>up 32%</font>; Media Delivery sales were $179M,&nbsp;<font color='red'>down 9%</font>; Services and Support were&nbsp;<font color='green'>up 12%</font>&nbsp;to $54M.&nbsp;</li><li>               Internet Platform Customers, which includes the likes of Amazon and Facebook, dragged revenue down with a reported $51M in sales,&nbsp;<font color='red'>down 17%</font>&nbsp;on the year.&nbsp;</li><li>               Cash from operations was $225M or 37% of overall sales. The company had $1.4B in cash and equivalents at the end of the quarter.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16896025-akamai-reports-second-quarter-2017-financial-results\" target=\"_blank\">Press release</a>.&nbsp;</li><li>               Akamai Technologies shares are&nbsp;<font color='red'>down 7%</font>&nbsp;aftermarket. &nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3281079-akamai-beats-0_02-beats-revenue\" target=\"_blank\">Akamai beats by $0.02, beats on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281216\" data-linked=\"Akamai beats Q2 estimates, shows game download weakness; shares down 7%\" data-tweet=\"$AKAM - Akamai beats Q2 estimates, shows game download weakness; shares down 7% https://seekingalpha.com/news/3281216-akamai-beats-q2-estimates-shows-game-download-weakness-shares-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3281216-akamai-beats-q2-estimates-shows-game-download-weakness-shares-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281205\" data-ts=\"1501016722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281205-exact-sciences-q2-top-line-up-172-net-loss-narrows-31-cologuard-test-volume-up-149-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exact Sciences Q2 top line up 172%; net loss narrows 31%; Cologuard test volume up 149%; shares ahead 4% after hours</a></h4><ul><li>Exact Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a>) <a href=\"https://seekingalpha.com/pr/16896064-cologuard-revenue-increased-57_6-million-second-quarter-test-volume-grew-149-percent-second\" target=\"_blank\">Q2 results</a> ($M): Lab Service Revenue: 57.6 (+171.7%).</li><li>Net Loss: (30.8) (+31.3%); Loss/Share: (0.27) (+41.3%).</li><li>Cologuard tests completed: 135K (+149%); average revenue per test: $428 (+9%); average cost per test: $133 (-28%); first-time prescribers: 11K.</li><li><strong>2017 Guidance</strong>: total number of Cologuard tests completed: at least 550K from at least 470K; revenue: $230M - 240M.</li><li><strong>Q3 Guidance</strong>: at least 150K Cologuard tests to be completed.</li><li>Shares are up&nbsp;<font color='green'>4%</font>&nbsp;after hours on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281205\" data-linked=\"Exact Sciences Q2 top line up 172%; net loss narrows 31%; Cologuard test volume up 149%; shares ahead 4% after hours\" data-tweet=\"$EXAS - Exact Sciences Q2 top line up 172%; net loss narrows 31%; Cologuard test volume up 149%; shares ahead 4% after hours https://seekingalpha.com/news/3281205-exact-sciences-q2-top-line-up-172-net-loss-narrows-31-cologuard-test-volume-up-149-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3281205-exact-sciences-q2-top-line-up-172-net-loss-narrows-31-cologuard-test-volume-up-149-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281189\" data-ts=\"1501016157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281189-juniper-networks-posts-q2-beat-guides-in-line-for-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper Networks posts Q2 beat, guides in line for Q3</a></h4><ul>   <li>Juniper Networks (<a href=\"http://seekingalpha.com/symbol/JNPR\" target=\"_blank\">JNPR</a> <font color='green'>+1.7%</font>) is <font color='red'>down 1.5%</font> in postmarket action after posting <a href=\"https://seekingalpha.com/news/3281123-juniper-networks-beats-0_03-beats-revenue\" target=\"_blank\">Q2 results</a> that beat expectations and some merely in-line guidance for the current quarter.</li>    <li>Revenues rose 7% both Y/Y and Q/Q. Profits, meanwhile, rose 28% Y/Y and 65% from the prior quarter on a GAAP basis, to $179.8M. Non-GAAP net income rose 15% Y/Y and 24% sequentially.</li>    <li>\"We are executing on our strategy to lead the transformation to the cloud, and I am pleased with the continued strength in our cloud solutions,\" says CEO Rami Rahim.</li>    <li>Revenue breakout: Product, $917.2B (up 6.4%); Service, $391.7M (up 9%).</li>    <li>Product breakdown: Routing, $572.5M (down 0.4%); Switching, $276M (up 31.9%); Security, $68.7M (down 12.1%).</li>    <li>Revenues by vertical: Cloud, $379.6M (up 32.1%); Telecom/Cable, $562.4M (down 1.5%); Strategic Enterprise, $366.9M (up 1.1%).</li>    <li>For Q3, it's guiding to revenues of $1.29B-$1.35B (in line with consensus for $1.325B), gross margin of 61.5%-62.5%, and EPS of $0.55-$0.61 (in line with expectations for $0.58).</li>    <li><a href=\"http://investor.juniper.net/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16896139-juniper-networks-reports-preliminary-second-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3281189\" data-linked=\"Juniper Networks posts Q2 beat, guides in line for Q3\" data-tweet=\"$JNPR - Juniper Networks posts Q2 beat, guides in line for Q3 https://seekingalpha.com/news/3281189-juniper-networks-posts-q2-beat-guides-in-line-for-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3281189-juniper-networks-posts-q2-beat-guides-in-line-for-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281187\" data-ts=\"1501015851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESRX\" target=\"_blank\">ESRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281187-express-scripts-q2-top-line-up-5-earnings-up-11-cash-flow-up-75-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Express Scripts Q2 top line up 5%; earnings up 11%; cash flow up 75%; shares down 2% after hours</a></h4><ul><li>Express Scripts (NASDAQ:<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a>) <a href=\"https://seekingalpha.com/pr/16896026-express-scripts-announces-2017-second-quarter-results\" target=\"_blank\">Q2 results</a> ($M): Total Revenues: 25,347.5 (+5.0%).</li><li>Net Income: 801.8 (+11.3%); Non-GAAP Net Income: 1,011.6 (+1.3%); EPS: 1.37 (+21.2%); Non-GAAP EPS: 1.73 (+10.2%); CF Ops (6 mo.): 2,081.6 (+74.9%).</li><li>Claim volume: 248.3 (-1.0%).</li><li>Management believes its enterprise-wide initiative to transform the company by 2021 will deliver savings of $550M - 600M per year by then.</li><li><strong>2017 Guidance</strong>: Non-GAAP EPS: $6.95 - 7.05 from $6.90 - 7.04.</li><li><strong>Q3 Guidance</strong>: Non-GAAP EPS: $1.88 - 1.92.</li><li>2018 retention rate for 2017 selling season expected to be 94 - 96%.</li><li>Shares are down&nbsp;<font color='red'>2%</font>&nbsp;after hours on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281187\" data-linked=\"Express Scripts Q2 top line up 5%; earnings up 11%; cash flow up 75%; shares down 2% after hours\" data-tweet=\"$ESRX - Express Scripts Q2 top line up 5%; earnings up 11%; cash flow up 75%; shares down 2% after hours https://seekingalpha.com/news/3281187-express-scripts-q2-top-line-up-5-earnings-up-11-cash-flow-up-75-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3281187-express-scripts-q2-top-line-up-5-earnings-up-11-cash-flow-up-75-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281181\" data-ts=\"1501015597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281181-amd-sharesplus-6_8-after-q2-beat-computing-and-graphics-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD shares +6.8% after Q2 beat, Computing and Graphics growth</a></h4><ul><li>        Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) reports Q2 earnings with EPS and revenue beats.</li><li>               Computing and Graphics segment sales&nbsp;<font color='green'>up 51%</font>&nbsp;on the year to $659M and&nbsp;<font color='green'>24%</font>&nbsp;sequentially. Client and GPU ASPs were both up on the year, and operating income returns to the green with $7M compared to last year&rsquo;s $81M loss. Improvements were due to pricing and product mix.&nbsp;</li><li>               Enterprise, Embedded and Semi-Custom segment sales&nbsp;<font color='red'>down 5%&nbsp;</font>to $563 due to lower semi-custom SoC sales. Operating income dropped from last year&rsquo;s $84M to $42M due to lower sales and higher R^D investments in datacenters.&nbsp;&nbsp;&nbsp;</li><li>           Other segment also had an operating loss increase from $11M last year to $24M due to stock-based compensation charges and a $7M restructuring credit. </li><li> AMD ended the quarter with $844M in cash and equivalents. </li><li> Q3 guidance: revenue up 20% to 26% sequentially with the midpoint at about 15% year-over-year, which would put the actual number around $1.5B compared to the $1.39B consensus. </li><li> <a href=\"https://seekingalpha.com/pr/16896134-amd-reports-second-quarter-2017-financial-results\" target=\"_blank\">Press release</a> </li><li> AMD shares are&nbsp;<font color='green'>up 6.8%</font>&nbsp;aftermarket.&nbsp;<br /> </li><li>Previously: <a href=\"https://seekingalpha.com/news/3281136-advanced-micro-devices-beats-0_02-beats-revenue\" target=\"_blank\">Advanced Micro Devices beats by $0.02, beats on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281181\" data-linked=\"AMD shares +6.8% after Q2 beat, Computing and Graphics growth\" data-tweet=\"$AMD - AMD shares +6.8% after Q2 beat, Computing and Graphics growth https://seekingalpha.com/news/3281181-amd-sharesplus-6_8-after-q2-beat-computing-and-graphics-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3281181-amd-sharesplus-6_8-after-q2-beat-computing-and-graphics-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>140&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281180\" data-ts=\"1501015521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281180-u-s-steelplus-9-q2-earnings-full-year-outlook-far-exceed-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel +9% as Q2 earnings, full-year outlook far exceed estimates</a></h4><ul>     <li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='green'>+8.9%</font>&nbsp;AH after routing <a href=\"https://seekingalpha.com/news/3281144-u-s-nbsp-steel-beats-1_08-beats-revenue\" target=\"_blank\">Q2 earnings</a> expectations as revenues rose by a higher than expected 22% Y/Y.</li>     <li>EPS of $1.48 includes a $0.41 gain representing the recovery in excess of retained interest resulting from the sale of U. S. Steel Canada, but Q1 loss $1.03/share and Q2 2016 lost $0.32.</li>     <li>Q2 segment earnings improved by $300M from Q1, most of it in the flat-rolled segment, which the company credits to better operations combined with higher prices and volumes and improved results from mining operations.</li>     <li>X raises its FY 2017 EPS guidance to $1.70 from $1.50, far ahead of the $1.08 analyst consensus estimate, and consolidated EBITDA of ~$1.1B.</li>     <li>\"We are seeing a more bullish sentiment in the markets served by our Flat-Rolled and European segments right now, as prices have been increasing and  overall demand has been stable.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3281180\" data-linked=\"U.S. Steel +9% as Q2 earnings, full-year outlook far exceed estimates\" data-tweet=\"$X - U.S. Steel +9% as Q2 earnings, full-year outlook far exceed estimates https://seekingalpha.com/news/3281180-u-s-steelplus-9-q2-earnings-full-year-outlook-far-exceed-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3281180-u-s-steelplus-9-q2-earnings-full-year-outlook-far-exceed-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281178\" data-ts=\"1501015442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFTBY\" target=\"_blank\">SFTBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281178-irobot-soars-25-on-report-of-softbank-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IRobot soars 25% on report of Softbank stake</a></h4><ul><li>According to Bloomberg, Softbank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>, <a href='https://seekingalpha.com/symbol/SFTBF' title='SoftBank Group'>OTCPK:SFTBF</a>) has built a stake of just under 5% in iRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) as part of its tech buildout.</li><li>IRBT&nbsp;<font color='green'>+25.8%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3281178\" data-linked=\"IRobot soars 25% on report of Softbank stake\" data-tweet=\"$SFTBY $SFTBY $SFTBF - IRobot soars 25% on report of Softbank stake https://seekingalpha.com/news/3281178-irobot-soars-25-on-report-of-softbank-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3281178-irobot-soars-25-on-report-of-softbank-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281175\" data-ts=\"1501015331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281175-irobot-eps-of-0_27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">iRobot EPS of $0.27</a></h4><ul><li>iRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>): Q2 EPS of $0.27 may not be comparable to consensus of -$0.28.</li><li>Revenue of $183.15M (+23.2% Y/Y) <font color='green'>beats by $8.49M</font>.</li><li>Shares <font color='green'>+26%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16896163-irobot-reports-strong-second-quarter-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281175\" data-linked=\"iRobot EPS of $0.27\" data-tweet=\"$IRBT - iRobot EPS of $0.27 https://seekingalpha.com/news/3281175-irobot-eps-of-0_27?source=tweet\" data-url=\"https://seekingalpha.com/news/3281175-irobot-eps-of-0_27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281172\" data-ts=\"1501015174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281172-oil-jumps-late-on-bullish-inventory-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil jumps late on bullish inventory report</a></h4><ul><li>According to the API, crude inventories tumbled 10.2M barrels last week. Were the EIA to release a similar number tomorrow morning, it would be the largest draw since September. Trade estimates were for about a 3M barrel draw.</li><li>WTI crude has added more than $0.50 per barrel since the print, now&nbsp;<font color='green'>up 4.55%&nbsp;</font>on the session to $48.45.</li><li><a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>&nbsp;<font color='green'>gained 3.25%</font>&nbsp;in the regular session, and is&nbsp;<font color='green'>up another 1%</font>&nbsp;after hours.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281172\" data-linked=\"Oil jumps late on bullish inventory report\" data-tweet=\"$USO $OIL $UWT - Oil jumps late on bullish inventory report https://seekingalpha.com/news/3281172-oil-jumps-late-on-bullish-inventory-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3281172-oil-jumps-late-on-bullish-inventory-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>93&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281164\" data-ts=\"1501014755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMGN\" target=\"_blank\">AMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281164-amgen-q2-top-line-up-2-earnings-up-15-cash-flow-down-13-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amgen Q2 top line up 2%; earnings up 15%, cash flow down 13%; shares down 2% after hours</a></h4><ul><li>Amgen (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>)<a href=\"https://seekingalpha.com/pr/16896021-amgen-reports-second-quarter-2017-financial-results\" target=\"_blank\"> Q2 results</a> ($M): Total Revenues: 5,810 (+2.1%).</li><li>Net Income: 2,151 (+15.0%); Non-GAAP Net Income: 2,410 (+12.3%); EPS: 2.91 (+17.8%); Non-GAAP EPS: 3.27 (+15.1%); CF Ops: 2,326 (-13.1%).</li><li>Sales Leaders: Enbrel: 1,466 (-1.2%); Neulasta: 1,087 (-5.4%); Aranesp: 535 (+6.2%); Prolia: 505 (+14.5%); Sensipar/Mimpara: 427 (+9.8%).</li><li>Repatha: 83 (+207.4%); BLINCYTO: 43 (+43.3%); KYPROLIS: 211 (+22.7%).</li><li><strong>2017 Guidance</strong>: Total Revenues: $22.5B - 23.0B from $22.3B - 23.1B; EPS: $10.79 - 11.37 from $10.64 - 11.32; Non-GAAP EPS: $12.15 - 12.65 from $12.00 - 12.60; CAPEX: ~$700M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281164\" data-linked=\"Amgen Q2 top line up 2%; earnings up 15%, cash flow down 13%; shares down 2% after hours\" data-tweet=\"$AMGN - Amgen Q2 top line up 2%; earnings up 15%, cash flow down 13%; shares down 2% after hours https://seekingalpha.com/news/3281164-amgen-q2-top-line-up-2-earnings-up-15-cash-flow-down-13-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3281164-amgen-q2-top-line-up-2-earnings-up-15-cash-flow-down-13-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281159\" data-ts=\"1501014614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MORN\" target=\"_blank\">MORN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281159-morningstar-marks-q2-profit-on-broad-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morningstar marks Q2 profit on broad revenue growth</a></h4><ul>   <li>Morningstar (<a href=\"http://seekingalpha.com/symbol/MORN\" target=\"_blank\">MORN</a> <font color='green'>+1.8%</font>) grew net income on a headline basis in its <a href=\"https://seekingalpha.com/news/3281094-morningstar-reports-q2-results\" target=\"_blank\">Q2 earnings report</a> with the help of the sale of online business HelloWallet and broad revenue gains.</li>    <li>That HelloWallet sale brought a noncash after-tax gain of $18M ($0.42/share); net income grew to $46.1M ($1.07/share in GAAP terms) from $31.8M ($0.73/share) a year ago.</li>    <li>Meanwhile, recently acquired PitchBook Data contributed $15.1M in revenue; overall revenues rose 15.6% and organic revenue was up 9.2%.</li>    <li>Average assets under management and advisement grew nearly 13%, to $209.4B.</li>    <li>Revenue by key product: Morningstar Data, $40.6M (up 6.2%); Morningstar Direct, $30.7M (up 12.7%);  Morningstar Investment Management, $26.8M (up 9.7%); Morningstar Advisor Workstation, $22.8M (up 10.6%); Workplace Solutions, $19M (up 13.4%).</li>    <li>Revenue by type: License-based, $165.6M (up 16.5%); Asset-based, $46.9M (up 13.5%); Transaction-based, $16.7M (up 13.1%).</li>    <li><a href=\"https://seekingalpha.com/pr/16896060-morningstar-inc-reports-second-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3281159\" data-linked=\"Morningstar marks Q2 profit on broad revenue growth\" data-tweet=\"$MORN - Morningstar marks Q2 profit on broad revenue growth https://seekingalpha.com/news/3281159-morningstar-marks-q2-profit-on-broad-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3281159-morningstar-marks-q2-profit-on-broad-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281152\" data-ts=\"1501014323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFS\" target=\"_blank\">SFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281152-smart-and-amp-final-stores-misses-0_02-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smart &amp;amp; Final Stores misses by $0.02,  revenue in-line</a></h4><ul><li>Smart &amp; Final Stores (NYSE:<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores'>SFS</a>): Q2 EPS of $0.14 <font color='red'>misses by $0.02</font>.</li><li>Revenue of $1.08B (+3.8% Y/Y) in-line.</li><li>Shares <font color='green'>+4.94%</font>.</li><li><a href='https://seekingalpha.com/pr/16896126-smart-and-final-stores-inc-reports-second-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281152\" data-linked=\"Smart &amp;amp; Final Stores misses by $0.02,  revenue in-line\" data-tweet=\"$SFS - Smart &amp; Final Stores misses by $0.02, revenue in-line https://seekingalpha.com/news/3281152-smart-and-amp-final-stores-misses-0_02-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3281152-smart-and-amp-final-stores-misses-0_02-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281148\" data-ts=\"1501014209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMM\" target=\"_blank\">MMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281148-3ms-5-plunge-blamed-on-weak-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3M&#39;s 5% plunge blamed on weak pricing</a></h4><ul>     <li>3M (<a href='https://seekingalpha.com/symbol/MMM' title='3M Company'>MMM</a> <font color='red'>-5.1%</font>) closed with <a href=\"http://www.marketwatch.com/story/3m-cos-stock-faces-worst-ever-price-drop-caps-dows-mcdonalds-caterpillar-fueled-rally-2017-07-25\" target=\"_blank\">one of its worst-ever single-day losses</a>, falling $10.61 to below $200/share even after only slightly missing <a href=\"https://seekingalpha.com/news/3280861-3m-beats-0_07-misses-revenue\" target=\"_blank\">Q2 earnings</a> and revenue estimates and raising the low end of its full-year earnings guidance; the stock had gained 18%&nbsp;YTD through Monday's close.</li>     <li>Jefferies analyst Laurence Alexander <a href=\"http://www.barrons.com/articles/why-3m-is-tanking-1500997803\" target=\"_blank\">blames 3M's pricing for the negative reaction</a>, as the company says core pricing will be roughly flat in the U.S. in 2017 vs. a trend of 30-50 bps Y/Y globally, and price growth for its products in the U.S. is tracking toward the low end of expectations.</li>     <li>3M also says it took \"selected price adjustments\" in its industrial and consumer businesses to gain market share and accelerate volume growth; Q2 operating margins fell 420 bops in the industrial business to 19.2% and 770 bps in its consumer business to 17.2%.</li>     <li>&ldquo;We had thought expectations were quite high going into what might be a messy&rdquo; quarter, Credit Suisse's Julian Mitchell <a href=\"https://www.bloomberg.com/news/articles/2017-07-25/3m-s-outlook-disappoints-after-company-misses-profit-estimates\" target=\"_blank\">says</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281148\" data-linked=\"3M&#39;s 5% plunge blamed on weak pricing\" data-tweet=\"$MMM - 3M&#39;s 5% plunge blamed on weak pricing https://seekingalpha.com/news/3281148-3ms-5-plunge-blamed-on-weak-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3281148-3ms-5-plunge-blamed-on-weak-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281144\" data-ts=\"1501014144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281144-u-s-and-nbsp-steel-beats-1_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S.&amp;nbsp;Steel beats by $1.08, beats on revenue</a></h4><ul><li>U.S.&nbsp;Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>): Q2 EPS of $1.49 <font color='green'>beats by $1.08</font>.</li><li>Revenue of $3.14B (+21.7% Y/Y) <font color='green'>beats by $180M</font>.</li><li>Shares <font color='green'>+10.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16896132-united-states-steel-corporation-reports-second-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281144\" data-linked=\"U.S.&amp;nbsp;Steel beats by $1.08, beats on revenue\" data-tweet=\"$X - U.S.&amp;nbsp;Steel beats by $1.08, beats on revenue https://seekingalpha.com/news/3281144-u-s-and-nbsp-steel-beats-1_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3281144-u-s-and-nbsp-steel-beats-1_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281136\" data-ts=\"1501014035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281136-advanced-micro-devices-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advanced Micro Devices beats by $0.02, beats on revenue</a></h4><ul><li>Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>): Q2 EPS of $0.02 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $1.22B (+18.4% Y/Y) <font color='green'>beats by $60M</font>.</li><li>Shares <font color='green'>+8.7%</font>.</li><li><a href='https://seekingalpha.com/pr/16896134-amd-reports-second-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281136\" data-linked=\"Advanced Micro Devices beats by $0.02, beats on revenue\" data-tweet=\"$AMD - Advanced Micro Devices beats by $0.02, beats on revenue https://seekingalpha.com/news/3281136-advanced-micro-devices-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3281136-advanced-micro-devices-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>176&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281134\" data-ts=\"1501014002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281134-texas-instrumentsplus-2_6-after-q2-beat-positive-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Instruments +2.6% after Q2 beat, positive guidance</a></h4><ul><li>        Texas Instruments (NYSE:<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a>) reports Q2 results with beats on revenue and EPS. In the key segments, Analog revenues were&nbsp;<font color='green'>up 18%</font>&nbsp;to $2.4B, and Embedded Processing sales were&nbsp;<font color='green'>up 15%</font>&nbsp;to $868M. Other, which includes calculators and DLP products, had the only revenue drop,&nbsp;<font color='red'>down 13%</font>&nbsp;to $414M.&nbsp;</li><li>        Cash flow from operations reported at $4.6B for the trailing twelve months. Trailing FCF was $4B or 28.5% or revenue. Texas Instruments ended the quarter with $3B in cash and equivalents.</li><li>               Q3 guidance has revenue between $3.74B and $4.06B and EPS from $1.04 to $1.18. Consensus estimates have revenue at $3.8B and EPS at $1.05.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16896016-ti-reports-2q17-financial-results-shareholder-returns\" target=\"_blank\">Press release</a>.&nbsp;</li><li>Texas Instruments shares are&nbsp;<font color='green'>up 2.6%</font>&nbsp;aftermarket. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3281085-texas-instruments-beats-0_07-beats-revenue\" target=\"_blank\">Texas Instruments beats by $0.07, beats on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281134\" data-linked=\"Texas Instruments +2.6% after Q2 beat, positive guidance\" data-tweet=\"$TXN - Texas Instruments +2.6% after Q2 beat, positive guidance https://seekingalpha.com/news/3281134-texas-instrumentsplus-2_6-after-q2-beat-positive-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3281134-texas-instrumentsplus-2_6-after-q2-beat-positive-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281115\" data-ts=\"1501013676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281115-restaurant-margin-improves-chipotle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restaurant margin improves at Chipotle</a></h4><ul>     <li>Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) reports comparable sales increased 8.1% in <a href=\"https://seekingalpha.com/pr/16896047-chipotle-second-quarter-diluted-eps-increased-167-percent-comparable-restaurant-sales\" target=\"_blank\">Q2</a> vs. +9.5% consensus.</li>     <li>Restaurant-level operating margin popped to 18.8% vs. 15.5% a year ago.</li>     <li>Food/beverage/packaging costs as a percentage of sales fell 10 bps to 34.1%.</li>     <li>G&amp;A expenses were down 110 bps to 6.0% as a higher level of sales leveraged off some costs..</li>     <li>\"We saw encouraging signs in our improved financial results during the first half of the year. Recent events, however, have shown that we still have a lot of opportunity to improve our operations and deliver the outstanding experience that our customers expect,\" says CEO Steve Ells.</li>     <li>Chipotle says it expects comparable restaurant sales to increase at a high single-digit rate in 2017. The lack of a downward revision due to the recent negative publicity will be taken as a positive sign. The company expects to open between 195 and 210 restaurants this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3281089-chipotle-mexican-grill-beats-0_14-misses-revenue\" target=\"_blank\">Chipotle Mexican Grill beats by $0.14, misses on revenue</a> (July 25)</li>          <li>CMG&nbsp;<font color='green'>+2.40%</font>&nbsp;AH to $357.00 to follow on a 2.54% gain before the bell.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281115\" data-linked=\"Restaurant margin improves at Chipotle\" data-tweet=\"$CMG - Restaurant margin improves at Chipotle https://seekingalpha.com/news/3281115-restaurant-margin-improves-chipotle?source=tweet\" data-url=\"https://seekingalpha.com/news/3281115-restaurant-margin-improves-chipotle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281114\" data-ts=\"1501013639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSS\" target=\"_blank\">TSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281114-total-system-services-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Total System Services beats by $0.05, beats on revenue</a></h4><ul><li>Total System Services (NYSE:<a href='https://seekingalpha.com/symbol/TSS' title='Total System Services, Inc.'>TSS</a>): Q2 EPS of $0.85 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $844.07M (+6.2% Y/Y) <font color='green'>beats by $2.22M</font>.</li><li>Shares <font color='green'>+1.41%</font>.</li><li><a href='https://seekingalpha.com/pr/16896005-tsys-reports-second-quarter-earnings'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281114\" data-linked=\"Total System Services beats by $0.05, beats on revenue\" data-tweet=\"$TSS - Total System Services beats by $0.05, beats on revenue https://seekingalpha.com/news/3281114-total-system-services-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3281114-total-system-services-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281113\" data-ts=\"1501013583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTPH\" target=\"_blank\">TTPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281113-tetraphase-pharmas-eravacycline-on-par-meropenem-in-late-stage-study-in-complicated-intra\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetraphase Pharma&#39;s eravacycline on par with meropenem in late-stage study in complicated intra-abdominal infections; shares ahead 10% after hours</a></h4><ul><li>Tetraphase Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a>) <a href=\"https://seekingalpha.com/pr/16896023-tetraphase-announces-positive-top-line-results-phase-3-ignite4-clinical-trial-complicated\" target=\"_blank\">announces </a>positive results from a Phase 3 clinical trial, IGNITE4, assessing twice-daily intravenous &#40;IV&#41; eravacycline compared to meropenem in patients with complicated intra-abdominal infections (cIAI). Data from the 500-subject study showed statistical non-inferiority of eravacycline to meropenem as measured by clinical response at the test-of-cure visit.</li><li>The company plans to file its European marketing application this quarter and its U.S. marketing application in Q1 2018.</li><li>Shares are up&nbsp;<font color='green'>10%</font>&nbsp;after hours on robust volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3235811-late-stage-study-commences-evaluating-tetraphases-lead-candidate-eravacycline-cuti\" target=\"_blank\">Late-stage study commences evaluating Tetraphase's lead candidate eravacycline in cUTI</a> (Jan. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281113\" data-linked=\"Tetraphase Pharma&#39;s eravacycline on par with meropenem in late-stage study in complicated intra-abdominal infections; shares ahead 10% after hours\" data-tweet=\"$TTPH - Tetraphase Pharma&#39;s eravacycline on par with meropenem in late-stage study in complicated intra-abdominal infections; shares ahead 10% after hours https://seekingalpha.com/news/3281113-tetraphase-pharmas-eravacycline-on-par-meropenem-in-late-stage-study-in-complicated-intra?source=tweet\" data-url=\"https://seekingalpha.com/news/3281113-tetraphase-pharmas-eravacycline-on-par-meropenem-in-late-stage-study-in-complicated-intra\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281110\" data-ts=\"1501013529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281110-tplus-1_9-profits-beat-company-adds-wireless-subs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T +1.9% as profits beat, company adds wireless subs</a></h4><ul>   <li>AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) is <font color='green'>up 1.9%</font> after hours after topping expectations with its <a href=\"https://seekingalpha.com/news/3281080-amp-t-beats-0_05-revenue-line\" target=\"_blank\">Q2 earnings</a> though revenues dipped slightly Y/Y.</li>    <li>Sales fell to $39.8B from $40.5B mainly on declines in legacy wirelines and consumer mobility, the company said. But operating expenses fell to $32.5B from $34B.</li>    <li>In wireless, the company logged 2.8M net adds (2.3M U.S., and 476,000 in Mexico), and U.S. wireless logged its best-ever postpaid phone churn, of 0.79%. Total postpaid churn was 1.01%.</li>    <li>Entertainment Group marked 112,000 IP broadband net adds (8,000 net adds in total broadband). Video losses overall were 199,000; the company says DirecTV Now offset drops among traditional TV subs.</li>    <li>Cash from operations came to $8.9B; free cash flow was $3.7B. Capex was $5.2B (and $11.2B YTD).</li>    <li>It maintained full-year guidance.</li>    <li><a href=\"http://www.media-server.com/m/acs/be933dcc4261012d0f99d6c6de807145\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16896017-t-reports-second-quarter-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3281110\" data-linked=\"AT&amp;T +1.9% as profits beat, company adds wireless subs\" data-tweet=\"$T - AT&amp;T +1.9% as profits beat, company adds wireless subs https://seekingalpha.com/news/3281110-tplus-1_9-profits-beat-company-adds-wireless-subs?source=tweet\" data-url=\"https://seekingalpha.com/news/3281110-tplus-1_9-profits-beat-company-adds-wireless-subs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281102\" data-ts=\"1501013374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMP\" target=\"_blank\">AMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281102-ameriprise-financial-beats-0_18-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ameriprise Financial beats by $0.18, beats on revenue</a></h4><ul><li>Ameriprise Financial (NYSE:<a href='https://seekingalpha.com/symbol/AMP' title='Ameriprise Financial, Inc.'>AMP</a>): Q2 EPS of $2.80 <font color='green'>beats by $0.18</font>.</li><li>Revenue of $2.99B (+4.2% Y/Y) <font color='green'>beats by $70M</font>.</li><li>Shares <font color='green'>+1.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16896089-ameriprise-financial-reports-second-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281102\" data-linked=\"Ameriprise Financial beats by $0.18, beats on revenue\" data-tweet=\"$AMP - Ameriprise Financial beats by $0.18, beats on revenue https://seekingalpha.com/news/3281102-ameriprise-financial-beats-0_18-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3281102-ameriprise-financial-beats-0_18-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281098\" data-ts=\"1501013310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVTY\" target=\"_blank\">IVTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281098-invuity-misses-0_07-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invuity misses by $0.07, misses on revenue</a></h4><ul><li>Invuity (NASDAQ:<a href='https://seekingalpha.com/symbol/IVTY' title='Invuity'>IVTY</a>): Q2 EPS of -$0.61 <font color='red'>misses by $0.07</font>.</li><li>Revenue of $9.8M (+19.2% Y/Y) <font color='red'>misses by $0.49M</font>.</li><li>Shares <font color='green'>+1.3%</font>.</li><li><a href='https://seekingalpha.com/pr/16896024-invuity-reports-2017-second-quarter-six-month-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281098\" data-linked=\"Invuity misses by $0.07, misses on revenue\" data-tweet=\"$IVTY - Invuity misses by $0.07, misses on revenue https://seekingalpha.com/news/3281098-invuity-misses-0_07-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3281098-invuity-misses-0_07-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281091\" data-ts=\"1501013218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXAS\" target=\"_blank\">EXAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281091-exact-sciences-beats-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EXACT Sciences beats by $0.08, beats on revenue</a></h4><ul><li>EXACT Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a>): Q2 EPS of -$0.27 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $57.6M (+172.0% Y/Y) <font color='green'>beats by $7.76M</font>.</li><li>Shares <font color='green'>+10.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16896064-cologuard-revenue-increased-57_6-million-second-quarter-test-volume-grew-149-percent-second'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281091\" data-linked=\"EXACT Sciences beats by $0.08, beats on revenue\" data-tweet=\"$EXAS - EXACT Sciences beats by $0.08, beats on revenue https://seekingalpha.com/news/3281091-exact-sciences-beats-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3281091-exact-sciences-beats-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281085\" data-ts=\"1501013101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281085-texas-instruments-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Instruments beats by $0.07, beats on revenue</a></h4><ul><li>Texas Instruments (NYSE:<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a>): Q2 EPS of $1.03 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $3.69B (+12.8% Y/Y) <font color='green'>beats by $120M</font>.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/16896016-ti-reports-2q17-financial-results-shareholder-returns'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281085\" data-linked=\"Texas Instruments beats by $0.07, beats on revenue\" data-tweet=\"$TXN - Texas Instruments beats by $0.07, beats on revenue https://seekingalpha.com/news/3281085-texas-instruments-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3281085-texas-instruments-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281080\" data-ts=\"1501012998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281080-andt-beats-0_05-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;amp;T beats by $0.05,  revenue in-line</a></h4><ul><li>AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>): Q2 EPS of $0.79 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $39.8B (-1.8% Y/Y) in-line.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/16896017-t-reports-second-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281080\" data-linked=\"AT&amp;amp;T beats by $0.05,  revenue in-line\" data-tweet=\"$T - AT&amp;T beats by $0.05, revenue in-line https://seekingalpha.com/news/3281080-andt-beats-0_05-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3281080-andt-beats-0_05-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281070\" data-ts=\"1501012004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ST\" target=\"_blank\">ST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281070-sensata-technology-shares-up-3_8-after-earnings-beat-analyst-pt-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sensata Technology shares up 3.8% after earnings beat, analyst PT increase</a></h4><ul><li>        Sensata Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ST' title='Sensata Technologies Holding N.V.'>ST</a>) shares up this afternoon after RBC Capital raises the price target by $4 to $50 while maintaining an Outperform rating.</li><li>               The firm cites this morning&rsquo;s Q2 revenue and EPS beats that came in above consensus midpoints.&nbsp;</li><li>               Source: <a href=\"https://www.streetinsider.com/Analyst+Comments/Sensata+Technologies+%28ST%29+PT+Raised+to+%2450+at+RBC+Capital+Following+Solid+2Q/13127190.html\" target=\"_blank\">StreetInsider</a>.&nbsp;</li><li>                  Sensata shares are&nbsp;<font color='green'>up 3.8%</font>&nbsp;to $46.82.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3280805-sensata-technologies-beats-0_03-beats-revenue\" target=\"_blank\">Sensata Technologies beats by $0.03, beats on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281070\" data-linked=\"Sensata Technology shares up 3.8% after earnings beat, analyst PT increase\" data-tweet=\"$ST - Sensata Technology shares up 3.8% after earnings beat, analyst PT increase https://seekingalpha.com/news/3281070-sensata-technology-shares-up-3_8-after-earnings-beat-analyst-pt-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3281070-sensata-technology-shares-up-3_8-after-earnings-beat-analyst-pt-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281069\" data-ts=\"1501011999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCA\" target=\"_blank\">HCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281069-hospitals-in-red-on-gop-health-plan-vote\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospitals in the red on GOP health plan vote</a></h4><ul><li>As usual, hospital operators are under pressure on the perceived risk to revenues and earnings if the Republicans get their way on healthcare. On the narrowest of margins (51/50 with VP Pence casting the deciding vote) the Senate agreed to debate the House version of the bill, itself narrowly passed in May.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='red'>-4.4%</font>)(<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='red'>-7.9%</font>)(<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='red'>-10.1%</font>)(<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='red'>-2.1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280993-senate-republicans-bailing-healthcare-plan-just-yet-procedural-vote-today-decide-start-debate\" target=\"_blank\">Senate Republicans not bailing on healthcare plan just yet, procedural vote today to decide on start of debate on House version</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281069\" data-linked=\"Hospitals in the red on GOP health plan vote\" data-tweet=\"$HCA $HCA $HUM - Hospitals in the red on GOP health plan vote https://seekingalpha.com/news/3281069-hospitals-in-red-on-gop-health-plan-vote?source=tweet\" data-url=\"https://seekingalpha.com/news/3281069-hospitals-in-red-on-gop-health-plan-vote\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281066\" data-ts=\"1501011168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281066-freeportplus-14-boosted-higher-copper-price-grasberg-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport +14%, boosted by higher copper price, Grasberg optimism</a></h4><ul>     <li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+14.2%</font>) is today's top performer on the S&amp;P 50, as <a href=\"http://www.reuters.com/article/us-freeport-mcmoran-results-idUSKBN1AA1FK\" target=\"_blank\">investors brush</a> aside below consensus <a href=\"https://seekingalpha.com/news/3280889-freeport-mcmoran-misses-0_04-beats-revenue\" target=\"_blank\">Q2 earnings</a> and full-year forecasts to focus instead on soaring copper prices and <a href=\"https://seekingalpha.com/news/3280910-freeport-mcmoran-plus-2-percent-q2-swings-profit\" target=\"_blank\">CEO Richard Adkerson's confidence</a> in securing a new mining agreement by October for the giant Grasberg mine.</li>     <li>&ldquo;We are now approaching a stage where both parties have expressed an objective of a near-term resolution,&rdquo; Adkerson <a href=\"https://www.ft.com/content/feb60078-7154-11e7-aca6-c6bd07df1a3c\" target=\"_blank\">said</a> in today's earnings conference call. \"I believe we are seeing that objective being more clearly identified by senior levels in the Indonesian government than we have seen in the past.\"</li>     <li>\"Freeport's <a href=\"http://www.reuters.com/article/us-freeport-mcmoran-results-idUSKBN1AA1FK\" target=\"_blank\">share price performance is justified</a> based on what's happened in copper, based on the progress in negotiations and based on the fact that... the stock is not very widely held,\" said Jefferies mining analyst Christopher LaFemina. \"This is a stock that many investors have not liked. It's under-owned and has had some good news. That tends to be a recipe for a higher share price.\"</li>     <li>Copper prices rose today to their highest in more than two years after the IMF <a href=\"https://seekingalpha.com/news/3280438-imf-cuts-u-s-growth-forecast-maintains-global-outlook\" target=\"_blank\">yesterday</a> maintained its strong growth outlook for China, the world&rsquo;s largest copper consumer.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3281066\" data-linked=\"Freeport +14%, boosted by higher copper price, Grasberg optimism\" data-tweet=\"$FCX $FCX $JJCTF - Freeport +14%, boosted by higher copper price, Grasberg optimism https://seekingalpha.com/news/3281066-freeportplus-14-boosted-higher-copper-price-grasberg-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3281066-freeportplus-14-boosted-higher-copper-price-grasberg-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281064\" data-ts=\"1501010618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281064-celgene-to-pay-280m-to-settle-whistleblower-suit-over-cancer-drug-marketing-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene to pay $280M to settle whistleblower suit over cancer drug marketing; shares down 1%</a></h4><ul><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='red'>-0.8%</font>) eases on light volume on the heels of the <a href=\"https://www.bloomberg.com/news/articles/2017-07-25/celgene-agrees-to-pay-280-million-to-settle-whistle-blower-suit\" target=\"_blank\">news </a>that it has agreed to pay $280M to settle a whistleblower's lawsuit claiming it used illegal marketing tactics to promote multiple myeloma meds Thalomid (thalidomide) and Revlimid (lenalidomide).</li><li>The company decided to pay up to resolve the case brought by former salesperson Beverly Brown who claimed the company defrauded federal and state Medicare programs out of billions of dollars by enticing doctors to prescribe the drugs for unapproved uses.</li><li>Celgene has yet to comment on the matter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281064\" data-linked=\"Celgene to pay $280M to settle whistleblower suit over cancer drug marketing; shares down 1%\" data-tweet=\"$CELG - Celgene to pay $280M to settle whistleblower suit over cancer drug marketing; shares down 1% https://seekingalpha.com/news/3281064-celgene-to-pay-280m-to-settle-whistleblower-suit-over-cancer-drug-marketing-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3281064-celgene-to-pay-280m-to-settle-whistleblower-suit-over-cancer-drug-marketing-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281239\" data-ts=\"1501010068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281239-anadarko-rewarded-investors-after-trimming-300m-from-2017-capex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadarko rewarded by investors after trimming $300M from 2017 capex</a></h4><ul>     <li>Anadarko Petroleum (<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color='green'>+3.4%</font>) pushes higher following its announced <a href=\"https://seekingalpha.com/news/3280710-anadarko-petro-minus-4-percent-q2-bleeds-red-ink-cuts-2017-capex-300m\" target=\"_blank\">$300M in 2017 spending cuts</a>, as U.S. shale companies show the <a href=\"https://www.bloomberg.com/news/articles/2017-07-24/anadarko-cuts-drilling-plan-as-oil-explorers-bow-to-price-slump\" target=\"_blank\">first signs of retrenching</a> due to the low prices they helped inflict.</li>     <li>&ldquo;If Wall Street rewards [Anadarko] for being more reserved with their activity levels and capital expenditures, then maybe it catches on,\" says Global Seaport's Mike Kelly, while if APC shares suffer, &ldquo;other people will be reticent about coming out and saying, &lsquo;we&rsquo;re cutting as well.&rsquo;\"</li>     <li>APC&rsquo;s move follows yesterday's assessment from top fracking services provider Halliburton, whose CEO&nbsp;Dave Lesar said the U.S. oil surge is &ldquo;showing signs of plateauing, and customers are <a href=\"https://seekingalpha.com/news/3280578-halliburton-turns-red-u-s-shale-firms-tapping-brakes\" target=\"_blank\">tapping on the brakes</a>.\"</li>     <li>Kelly notes that APC faced some unique circumstances in Q2: Production volumes have dropped in Colorado after April's fatal house explosion as the company's shutting down 3K wells in the state for further inspections.</li>     <li>And as Bloomberg's Liam Denning notes, APC is <a href=\"https://www.bloomberg.com/gadfly/articles/2017-07-25/anadarko-petroleum-earnings-braking-point\" target=\"_blank\">not cutting back in its core shale positions</a> in Colorado's Denver-Julesburg Basin and the Delaware area of the Permian Basin; Q2 capital spending on the two basins totaled $461M, up 20% Q/Q, and APC still expects production there to end 2017 at ~150K bbl/day, more than a third higher than the average for Q2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281239\" data-linked=\"Anadarko rewarded by investors after trimming $300M from 2017 capex\" data-tweet=\"$APC - Anadarko rewarded by investors after trimming $300M from 2017 capex https://seekingalpha.com/news/3281239-anadarko-rewarded-investors-after-trimming-300m-from-2017-capex?source=tweet\" data-url=\"https://seekingalpha.com/news/3281239-anadarko-rewarded-investors-after-trimming-300m-from-2017-capex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281057\" data-ts=\"1501008920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281057-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/MIND' title='Mitcham Industries, Inc.'>MIND</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BLIN' title='Bridgeline Digital, Inc.'>BLIN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/MTLS' title='Materialise NV'>MTLS</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/HSTM' title='HealthStream, Inc.'>HSTM</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LOGI' title='Logitech International S.A.'>LOGI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281057\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$QBAK $MIND $VJET - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3281057-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3281057-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281054\" data-ts=\"1501008134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTX\" target=\"_blank\">UTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281054-united-tech-tumbles-investors-still-waiting-for-news-on-new-jet-engine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Tech tumbles as investors still waiting for news on new jet engine</a></h4><ul>     <li>United Technologies (<a href='https://seekingalpha.com/symbol/UTX' title='United Technologies Corporation'>UTX</a> <font color='red'>-1.8%</font>) is lower despite reporting better than expected <a href=\"https://seekingalpha.com/news/3280834-united-technologies-beats-0_07-beats-revenue\" target=\"_blank\">Q2 earnings</a> and raising its full-year sales guidance to $58.5B-$59.5B, up from  $57.5B-$59B and lifts to lower end of its EPS forecast to $6.45-$6.60 from  $6.30-$6.60 earlier.</li>     <li>Investors apparently were <a href=\"https://www.bloomberg.com/gadfly/articles/2017-07-25/united-technologies-is-still-waiting-on-a-jet-plane\" target=\"_blank\">hoping for better guidance news</a>, since full-year $6.60 EPS still would&nbsp;represent a decline from a year ago as the company works through the investment costs involved in rolling out its new geared turbofan jet engine.</li><li>UTX offered no specifics on whether deliveries of the new engine are keeping pace and putting the company on track to reap the profit recovery that should come as the program matures.</li>     <li>Stifel's Robert McCarthy says UTX's Q2 also was <a href=\"http://www.barrons.com/articles/united-technologies-the-eye-of-the-beholder-1501000018\" target=\"_blank\">not as strong as it looked</a> at first glance, with \"segment profit in-line but aided by lower [corporate], tax and interest expense than we were modelling,\" while the guidance nudge was \"welcome but not surprising given CEO Hayes telegraphed this at an investor event at Paris Air Show in June.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3281054\" data-linked=\"United Tech tumbles as investors still waiting for news on new jet engine\" data-tweet=\"$UTX - United Tech tumbles as investors still waiting for news on new jet engine https://seekingalpha.com/news/3281054-united-tech-tumbles-investors-still-waiting-for-news-on-new-jet-engine?source=tweet\" data-url=\"https://seekingalpha.com/news/3281054-united-tech-tumbles-investors-still-waiting-for-news-on-new-jet-engine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281049\" data-ts=\"1501006293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDS\" target=\"_blank\">DDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281049-retail-sector-puts-on-rally-cap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail sector puts on its rally cap</a></h4><ul> <li>Retail chain stocks are riding high amid a strong day for the sector in general. Department store names and apparel sellers are leading the charge. The sentiment could be tied to a variety of factors-- including a strong read on consumer confidence, a wave of analysts and activist investors pointing to M&amp;A potential and some solid earnings reports. In many cases, the retail stocks listed below are recovering from extended sell-offs.</li> <li>Gainers include Dillard's (<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a> <font color='green'>+8%</font>), Sears Holdings (SHLD <font color='green'>+6.5%</font>), J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='green'>+4.9%</font>), Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='green'>+3.7%</font>), TJX Companies (<a href='https://seekingalpha.com/symbol/TJX' title='TJX Companies Inc.'>TJX</a> <font color='green'>+3.3%</font>), Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='green'>+2.8%</font>), Stein Mart (<a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='green'>+8.7%</font>), Tailored Brands (<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='green'>+9.3%</font>), Tilly's (<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+6.8%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color='green'>+5.4%</font>), Chico's (<a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a> <font color='green'>+2.7%</font>), New York &amp; Company (NWY <font color='green'>+5.4%</font>), Cherokee (<a href='https://seekingalpha.com/symbol/CHKE' title='Cherokee Inc.'>CHKE</a> <font color='green'>+5.6%</font>), American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+4.7%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='green'>+4.2%</font>), Tilly's (<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+6.8%</font>), GNC Holdings (<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a> <font color='green'>+6.5%</font>), Hibbett Sports (<a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='green'>+8.4%</font>), Signet Jewelers (<a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a> <font color='green'>+4.1%</font>), The Container Store (<a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a> <font color='green'>+4.6%</font>), Big Lots (<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> <font color='green'>+4%</font>), L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='green'>+3.3%</font>).</li> <li>Wal-Mart (<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> <font color='green'>+2.1%</font>) and Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='green'>+2.1%</font>) aren't missing the retail party, while the broad-based SPDR S&amp;P Retail ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is <font color='green'>up 2.57%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3281049\" data-linked=\"Retail sector puts on its rally cap\" data-tweet=\"$DDS $DDS $SHLDQ - Retail sector puts on its rally cap https://seekingalpha.com/news/3281049-retail-sector-puts-on-rally-cap?source=tweet\" data-url=\"https://seekingalpha.com/news/3281049-retail-sector-puts-on-rally-cap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281045\" data-ts=\"1501005676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281045-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ERN' title='Erin Energy Corp.'>ERN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CLB' title='Core Laboratories'>CLB</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281045\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$PACD $SRCI $FCX - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3281045-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3281045-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281041\" data-ts=\"1501004614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVC\" target=\"_blank\">IVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281041-fda-oks-restart-of-invacares-ohio-manufacturing-site-shares-ahead-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs restart of Invacare&#39;s Ohio manufacturing site; shares ahead 21%</a></h4><ul><li>Invacare (<a href='https://seekingalpha.com/symbol/IVC' title='Invacare Corporation'>IVC</a> <font color='green'>+20.6%</font>) is up on triple normal volume in response to its <a href=\"https://seekingalpha.com/pr/16895333-invacare-reaches-new-consent-decree-milestone\" target=\"_blank\">announcement </a>that the FDA has notified it that it has satisfied all the requirements under the consent decree to resume full operations at its Corporate and Taylor Street manufacturing facility in Elyria, OH.</li><li>The company says its can now produce and sell all products made at the site without the previous restrictions that have been in effect since December 2012. The <a href=\"http://www.morningjournal.com/article/MJ/20121221/NEWS/312219986\" target=\"_blank\">decree </a>applied to issues with quality and design work at its wheelchair factory and corporate facility, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281041\" data-linked=\"FDA OKs restart of Invacare&#39;s Ohio manufacturing site; shares ahead 21%\" data-tweet=\"$IVC - FDA OKs restart of Invacare&#39;s Ohio manufacturing site; shares ahead 21% https://seekingalpha.com/news/3281041-fda-oks-restart-of-invacares-ohio-manufacturing-site-shares-ahead-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3281041-fda-oks-restart-of-invacares-ohio-manufacturing-site-shares-ahead-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281039\" data-ts=\"1501003817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGEN\" target=\"_blank\">CGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281039-compugen-nabs-u-s-patent-covering-lead-i-o-candidate-com701-shares-ahead-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compugen nabs U.S. patent covering lead I-O candidate COM701; shares ahead 16%</a></h4><ul><li>Thinly traded micro cap Compugen (<a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a> <font color='green'>+16.2%</font>) is up on almost a 50% spike in volume in response to its <a href=\"https://seekingalpha.com/pr/16894980-compugen-announces-issuance-u-s-patent-com701-lead-immuno-oncology-product-candidate\" target=\"_blank\">announcement </a>that the USPTO has issued a new method of use patent covering lead immuno-oncology therapeutic antibody candidate COM701 (U.S. Patent No. 9,714,289).</li><li>The patent was issued under the USPTO's pilot program that provides early review for patent applications related to cancer immunotherapy in support of the White House Cancer Moonshot program.</li><li>COM701 is a humanized hybridoma antibody that binds to an immune checkpoint target called PVRIG.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281039\" data-linked=\"Compugen nabs U.S. patent covering lead I-O candidate COM701; shares ahead 16%\" data-tweet=\"$CGEN - Compugen nabs U.S. patent covering lead I-O candidate COM701; shares ahead 16% https://seekingalpha.com/news/3281039-compugen-nabs-u-s-patent-covering-lead-i-o-candidate-com701-shares-ahead-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3281039-compugen-nabs-u-s-patent-covering-lead-i-o-candidate-com701-shares-ahead-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281028\" data-ts=\"1501002681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZTS\" target=\"_blank\">ZTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281028-zoetis-under-pressure-on-softness-in-lillys-animal-health-unit-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoetis under pressure on softness in Lilly&#39;s animal health unit, shares down 3%</a></h4><ul><li>Zoetis (<a href='https://seekingalpha.com/symbol/ZTS' title='Zoetis'>ZTS</a> <font color='red'>-2.8%</font>) eases on more than a 20% higher volume as investors back away from the animal health space after Eli Lilly's soft Q2.</li><li>Lilly's animal health business <a href=\"https://seekingalpha.com/pr/16894902-lilly-reports-second-quarter-results\" target=\"_blank\">booked </a>~$785M in Q2, down 9% while food animal revenue was $473M, down 14%. The company attributed the softness to \"market access pressure\" and \"pressure in cattle and swine\" adding that \"it expects these pressures to continue.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3281028\" data-linked=\"Zoetis under pressure on softness in Lilly&#39;s animal health unit, shares down 3%\" data-tweet=\"$ZTS - Zoetis under pressure on softness in Lilly&#39;s animal health unit, shares down 3% https://seekingalpha.com/news/3281028-zoetis-under-pressure-on-softness-in-lillys-animal-health-unit-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3281028-zoetis-under-pressure-on-softness-in-lillys-animal-health-unit-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281034\" data-ts=\"1501002117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281034-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BSRR' title='Sierra Bancorp'>BSRR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='green'>+9%</font>.<a href='https://seekingalpha.com/symbol/MC' title='Moelis & Company'>MC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/WASH' title='Washington Trust Bancorp, Inc.'>WASH</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/PEBO' title='Peoples Bancorp Inc.'>PEBO</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AI' title='Arlington Asset Investment Corporation'>AI</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281034\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$BSRR $PN $MC - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3281034-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3281034-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281033\" data-ts=\"1501001962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281033-gevo-joins-indias-praj-to-commercialize-isobutanol-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo joins with India&#39;s Praj to commercialize isobutanol technology</a></h4><ul>     <li>Gevo (<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+11.8%</font>) is sharply higher after announcing with India's Praj Industries that Gevo&rsquo;s isobutanol technology will become <a href=\"https://seekingalpha.com/pr/16895449-praj-gevo-joint-development-agreement-enter-commercialization-phase\" target=\"_blank\">available for licensing</a> to processors of sugar cane juice and molasses.</li>     <li>Gevo expects licensing will be focused on Praj plants located in India, South America and southeast Asia, with initial capacity targeted to come online in 2019-20.</li>     <li>Praj says it has worked on 750 projects for ethanol plants across 75 countries, and that Gevo's isobutanol platform can be offered as a bolt-on to an existing  ethanol plant or as a greenfield plant.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281033\" data-linked=\"Gevo joins with India&#39;s Praj to commercialize isobutanol technology\" data-tweet=\"$GEVO - Gevo joins with India&#39;s Praj to commercialize isobutanol technology https://seekingalpha.com/news/3281033-gevo-joins-indias-praj-to-commercialize-isobutanol-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/3281033-gevo-joins-indias-praj-to-commercialize-isobutanol-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281030\" data-ts=\"1501001506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281030-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/IVC' title='Invacare Corporation'>IVC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ASPS' title='Altisource Portfolio Solutions SA'>ASPS</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-53%</font>. <a href='https://seekingalpha.com/symbol/TISI' title='Team, Inc.'>TISI</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/HSII' title='Heidrick & Struggles International, Inc.'>HSII</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='red'>-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281030\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SLRX $IVC $PACD - Midday Gainers / Losers https://seekingalpha.com/news/3281030-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3281030-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281025\" data-ts=\"1501000956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281025-restaurant-stocks-energized-mcdonalds-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Restaurant stocks energized by McDonald&#39;s results</a></h4><ul> <li>38 out of the 50 restaurants stocks with a market cap of over $50M are in positive territory after McDonald's (<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a> <font color='green'>+4.3%</font>) tops  comparable sales and profit estimates with its Q2 report.</li> <li>Notable gainers include Zoe's Kitchen (<a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a> <font color='green'>+6.9%</font>), Ruby Tuesday (<a href='https://seekingalpha.com/symbol/RT' title='Ruby Tuesday, Inc.'>RT</a> <font color='green'>+9.3%</font>), Arcos Dorados (<a href='https://seekingalpha.com/symbol/ARCO' title='Arcos Dorados'>ARCO</a> <font color='green'>+6.2%</font>), El Pollo Loco (<a href='https://seekingalpha.com/symbol/LOCO' title='El Pollo Loco Holdings'>LOCO</a> <font color='green'>+3.8%</font>), Del Taco (<a href='https://seekingalpha.com/symbol/TACO' title='Del Taco Restaurants, Inc.'>TACO</a> <font color='green'>+4.1%</font>), Bojangles (<a href='https://seekingalpha.com/symbol/BOJA' title='Bojangles&#39;'>BOJA</a> <font color='green'>+2.7%</font>), Buffalo Wild Wings (<a href='https://seekingalpha.com/symbol/BWLD' title='Buffalo Wild Wings, Inc.'>BWLD</a> <font color='green'>+1.8%</font>), Noodles (<a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='green'>+2.5%</font>), Chuy's Holdings (<a href='https://seekingalpha.com/symbol/CHUY' title='Chuy&#39;s Holdings'>CHUY</a> <font color='green'>+2.1%</font>) and Brinker International (<a href='https://seekingalpha.com/symbol/EAT' title='Brinker International, Inc.'>EAT</a> <font color='green'>+2.1%</font>).</li> <li>Within the hamburger subsector, investors have their eyes on the strong demand cited by McDonald's for its premium burgers ($5 to $7). It's unclear if the McDonald's trend is a sign that the company is simply taking hamburger market share or that overall restaurant traffic is on the mend after independent chains and grocery store price deflation nipped at traffic for Shake Shack (<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a> <font color='green'>+1.6%</font>), Restaurants Brands (<a href='https://seekingalpha.com/symbol/QSR' title='Restaurant Brands International Inc.'>QSR</a> <font color='green'>+1.5%</font>), Jack In The Box (<a href='https://seekingalpha.com/symbol/JACK' title='Jack In The Box Inc.'>JACK</a> <font color='green'>+0.8%</font>), Sonic (<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='green'>+1.1%</font>), Habit Restaurants (<a href='https://seekingalpha.com/symbol/HABT' title='The Habit Restaurants'>HABT</a> <font color='green'>+0.3%</font>) and Wendy's (<a href='https://seekingalpha.com/symbol/WEN' title='The Wendy&#39;s Company'>WEN</a> <font color='green'>+0.6%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280885-mcdonalds-beats-0_11-beats-revenue\" target=\"_blank\">McDonald's beats by $0.11, beats on revenue</a> (July 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280901-comparable-sales-dazzle-mcdonalds\" target=\"_blank\">Comparable sales dazzle for McDonald's</a> (July 25)</li> <li>Related ETF: <a href='https://seekingalpha.com/symbol/MENU' title='USCF Restaurant Leaders ETF'>MENU</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281025\" data-linked=\"Restaurant stocks energized by McDonald&#39;s results\" data-tweet=\"$MCD $MCD $ZOES - Restaurant stocks energized by McDonald&#39;s results https://seekingalpha.com/news/3281025-restaurant-stocks-energized-mcdonalds-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3281025-restaurant-stocks-energized-mcdonalds-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281017\" data-ts=\"1500999772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281017-michael-kors-in-focus-after-high-end-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michael Kors in focus after high-end deal</a></h4><ul> <li>Michael Kors (KORS) is in focus after an eye-catching deal to add Jimmy Choo.</li><li>CEO John Idol tells <a href=\"http://www.cnbc.com/2017/07/25/this-will-not-be-the-last-acquisition-michael-kors-ceo-says-after-jimmy-choo-deal.html\" target=\"_blank\">CNBC</a> the company is focused on creating a \"luxury group\" and will be considering even more M&amp;A.</li> <li>\"We like the target given its solid financial footing, premium luxury positioning, and footwear leadership,\" Jefferies weighs in.</li> <li>\"Again, Michael Kors follows the path of Coach -- and again, on steroids,\" writes BNP Paribas' Luca Solca.</li> <li>Looking ahead, retail insiders will be watching to see what <a href=\"https://www.nytimes.com/2017/07/25/business/dealbook/jimmy-choo-michael-kors.html\" target=\"_blank\">new categories</a> Jimmy Choo enters with Michael Kors management at the helm.</li><li>Shares of Michael Kors have fought their way back into positive territory after an early decline.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280787-michael-kors-acquires-jimmy-choo\" target=\"_blank\">Michael Kors acquires Jimmy Choo</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281017\" data-linked=\"Michael Kors in focus after high-end deal\" data-tweet=\"$CPRI - Michael Kors in focus after high-end deal https://seekingalpha.com/news/3281017-michael-kors-in-focus-after-high-end-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3281017-michael-kors-in-focus-after-high-end-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281015\" data-ts=\"1500999508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281015-credit-suisse-likes-lilly-sees-10-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse likes Lilly, sees 10% upside</a></h4><ul><li>Despite the baricitinib setback, Credit Suisse remains bullish on Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-4.4%</font>) citing a solid Q2 beat and raised guidance.</li><li>The company raised sales guidance to a midpoint of $22.25B (from $22.05B) and midpoint EPS guidance to $4.15 (from $4.10).</li><li>Trulicity sales were well above expectations and Alimta and Humulin also came in better than expected.</li><li>Negatives: soft sales in Animal Health (10% below views) and disappointing Humalog sales.</li><li>OUTPERFORM/$89</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280851-refiling-u-s-marketing-application-arthritis-med-baricitinib-least-18-months-away-lilly-1\" target=\"_blank\">Refiling of U.S. marketing application for arthritis med baricitinib at least 18 months away, Lilly down 1%, Incyte down 4% premarket</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281015\" data-linked=\"Credit Suisse likes Lilly, sees 10% upside\" data-tweet=\"$LLY - Credit Suisse likes Lilly, sees 10% upside https://seekingalpha.com/news/3281015-credit-suisse-likes-lilly-sees-10-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3281015-credit-suisse-likes-lilly-sees-10-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281014\" data-ts=\"1500999387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBC\" target=\"_blank\">FBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281014-flagstar-bancorp-up-nearly-5-after-strong-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flagstar Bancorp up nearly 5% after strong results</a></h4><ul><li>Q2 net income of $41M or $0.71 per share vs. $47M and $0.66 earned one year ago.</li><li>ROA of 1% down 34 basis points Y/Y; ROE of 11.6% up four basis points.</li><li>Net interest income of $97M up from $77M; NIM of 2.77% up 14 basis points.</li><li>Noninterest income of $116M down from $128M.</li><li>Adjusted noninterest expense of $142M vs. $139M a year ago</li><li>Provisions were negligible this year and last.</li><li><a href='https://seekingalpha.com/symbol/FBC' title='Flagstar Bancorp, Inc.'>FBC</a><font color='green'> +4.75%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3280820-flagstar-beats-0_10-beats-net-interest-income\" target=\"_blank\">Flagstar beats by $0.10, beats on net interest income</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3281014\" data-linked=\"Flagstar Bancorp up nearly 5% after strong results\" data-tweet=\"$FBC - Flagstar Bancorp up nearly 5% after strong results https://seekingalpha.com/news/3281014-flagstar-bancorp-up-nearly-5-after-strong-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3281014-flagstar-bancorp-up-nearly-5-after-strong-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281013\" data-ts=\"1500999278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281013-pareteumplus-5-launches-4g-subscription-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +5% as it launches 4G subscription offering</a></h4><ul>   <li>Nanocap Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color='green'>up 5%</font> this morning after going live with <a href=\"https://seekingalpha.com/pr/16895295-pareteum-goes-live-launch-full-featured-4g-broadband-services-resulting-new-subscribers\" target=\"_blank\">4G broadband subscription services</a>.</li>    <li>That will allow its clients (providers like MVNOs, hosted on its managed services platform and cloud platform) to offer full-featured advanced mobile services to customers, such as mobile Web, IP telephony, gaming, videoconferencing and VR.</li>    <li>The project is live with its first customer, says CEO Vic Bozzo, and \"when fully ramped will mark a new milestone in the total number of monthly subscribers added to the growing Pareteum backlog.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3281013\" data-linked=\"Pareteum +5% as it launches 4G subscription offering\" data-tweet=\"$TEUM - Pareteum +5% as it launches 4G subscription offering https://seekingalpha.com/news/3281013-pareteumplus-5-launches-4g-subscription-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3281013-pareteumplus-5-launches-4g-subscription-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3281007\" data-ts=\"1500998502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3281007-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/COT' title='Cott Corporation'>COT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='green'>+6%</font>. LTEA <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HNI' title='HNI Corporation'>HNI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/JJSF' title='J & J Snack Foods Corp.'>JJSF</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3281007\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$COT $LBY $CYRX - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3281007-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3281007-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280998\" data-ts=\"1500996962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280998-galectin-nabs-u-s-patent-covering-lead-candidate-gr-mdminus-02-shares-ahead-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin nabs U.S. patent covering lead candidate GR-MD-02; shares ahead 8%</a></h4><ul><li>Thinly traded nano cap Galectin Therapeutics (<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+7.7%</font>) perks up on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16895326-patent-enhancing-immunotherapy-cancer-treatment-granted-galectin-therapeutics\" target=\"_blank\">announcement </a>that it has received a notice of allowance from the USPTO for a patent covering method of use of lead product candidate GR-MD-02 as a means to enhance anti-tumor activity and increase survival effects of combining GR-MD-02 with multiple immune modulators for multiple types of cancer. The new patent is the company's 17th in the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3280998\" data-linked=\"Galectin nabs U.S. patent covering lead candidate GR-MD-02; shares ahead 8%\" data-tweet=\"$GALT - Galectin nabs U.S. patent covering lead candidate GR-MD-02; shares ahead 8% https://seekingalpha.com/news/3280998-galectin-nabs-u-s-patent-covering-lead-candidate-gr-mdminus-02-shares-ahead-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3280998-galectin-nabs-u-s-patent-covering-lead-candidate-gr-mdminus-02-shares-ahead-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280995\" data-ts=\"1500996255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AETI\" target=\"_blank\">AETI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280995-american-electric-tech-scores-break-in-win-brazil-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Electric Tech scores &quot;break-in win&quot; with Brazil contract</a></h4><ul>     <li>American Electric Technologies (<a href='https://seekingalpha.com/symbol/AETI' title='American Electric Technologies, Inc.'>AETI</a> <font color='green'>+10.8%</font>) surges on news it was <a href=\"https://seekingalpha.com/pr/16895241-m-electric-brazil-announces-1_4m-substation-modernization-project-large-brazilian-mining\" target=\"_blank\">awarded a $1.4M contract</a> for a substation modernization project in Brazil, a step the company calls a \"break-in win\" for its Brazilian business.</li>     <li>The contract calls for AETI to provide specialized services for the modernization of a 138KV main substation for a large Brazilian mining conglomerate.</li>     <li>AETI also announces the opening of its newest Brazilian office in Belo Horizonte.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280995\" data-linked=\"American Electric Tech scores &quot;break-in win&quot; with Brazil contract\" data-tweet=\"$AETI $SLNG - American Electric Tech scores &quot;break-in win&quot; with Brazil contract https://seekingalpha.com/news/3280995-american-electric-tech-scores-break-in-win-brazil-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3280995-american-electric-tech-scores-break-in-win-brazil-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280990\" data-ts=\"1500994918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280990-citi-targets-higher-interest-rates-help-financial-sector-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi targets, higher interest rates help financial sector outperform</a></h4><ul><li>Holding its first Investor Day in years, Citigroup <a href=\"https://seekingalpha.com/news/3280872-citi-lays-targets-investor-day\" target=\"_blank\">laid out return on equity targets</a> higher than the Street expected. Shares are&nbsp;<font color='green'>higher by 3.1%</font>.</li><li>Turning to interest rates, a mini-pullback of late has been reversed, with the 10-year Treasury yield higher by 5.6 basis points to 2.313%.</li><li>It adds up to an excuse to start buying financials again - this after a few days of caution amid Q2 results. The <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> is&nbsp;<font color='green'>up 1.4%</font>&nbsp;vs. the S&amp;P 500's&nbsp;<font color='green'>0.3%&nbsp;</font>advance. <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> and <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> both&nbsp;<font color='green'>up 1.8%</font>.</li><li>Among the big gainers are Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='green'>+2.4%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='green'>+2.5%</font>), NYCB (<a href='https://seekingalpha.com/symbol/NYCB' title='New York Community Bancorp Inc.'>NYCB</a> <font color='green'>+2.6%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color='green'>+2%</font>), Schwab (<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a> <font color='green'>+1.9%</font>), MetLife (<a href='https://seekingalpha.com/symbol/MET' title='MetLife, Inc.'>MET</a> <font color='green'>+1.6%</font>), Voya Financial (<a href='https://seekingalpha.com/symbol/VOYA' title='Voya Financial, Inc.'>VOYA</a> <font color='green'>+2.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3280990\" data-linked=\"Citi targets, higher interest rates help financial sector outperform\" data-tweet=\"$BAC $XLF $KRE - Citi targets, higher interest rates help financial sector outperform https://seekingalpha.com/news/3280990-citi-targets-higher-interest-rates-help-financial-sector-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3280990-citi-targets-higher-interest-rates-help-financial-sector-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280961\" data-ts=\"1500994917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280961-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/IVC' title='Invacare Corporation'>IVC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-59%</font>. <a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/RVP' title='Retractable Technologies, Inc'>RVP</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3280961\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$SLRX $IVC $MBRX - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3280961-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3280961-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280975\" data-ts=\"1500992992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280975-biogens-spinraza-ramp-fails-to-excite-ionis-investors-shares-down-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen&#39;s Spinraza ramp fails to excite Ionis investors, shares down 8%</a></h4><ul><li>Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-7.9%</font>) slumps on slightly higher volume in apparent response to Biogen's Q2 results released this morning that included sales of $203M (+328%) for SMA med SPINRAZA (nusinersen), <a href=\"http://newsroom.biogen.com/press-release/corporate/biogen-idec-and-isis-pharmaceuticals-announce-global-collaboration-antisen-0\" target=\"_blank\">co-developed</a> by companies under a 2012 agreement (Ionis receives a royalty of 12 - 15% of sales).</li><li>Biogen has stated that it expects SPINRAZA to generate peak sales of $1B - 2B so the Q2 results appear inline with this expectation. Analysts have projected that it will surpass the $1B mark within a year of launch which may be stretch. In order to achieve this, Q3 and Q4 sales would each have to increase ~40% sequentially ($250M - $350M - $490M).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280856-biogen-q2-revenues-6-percent-updates-guidance-shares-ahead-5-percent-premarket\" target=\"_blank\">Biogen Q2 revenues up 6%; updates guidance; shares ahead 5% premarket</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3280975\" data-linked=\"Biogen&#39;s Spinraza ramp fails to excite Ionis investors, shares down 8%\" data-tweet=\"$IONS - Biogen&#39;s Spinraza ramp fails to excite Ionis investors, shares down 8% https://seekingalpha.com/news/3280975-biogens-spinraza-ramp-fails-to-excite-ionis-investors-shares-down-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3280975-biogens-spinraza-ramp-fails-to-excite-ionis-investors-shares-down-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280981\" data-ts=\"1500992933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280981-dollar-continues-to-fade-fomc-begins-two-day-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar continues to fade as FOMC begins two-day meeting</a></h4><ul><li>No action is expected by the Fed this week, but tomorrow's policy statement will be parsed for clues about the chances of a September rate hike.</li><li>The Fed, however, is no longer the only hawkish major central bank. In fact, with a few FOMC members publicly voicing reservations about any further tightening this year, the Fed before long may find itself among the more dovish of the central banks.</li><li>Dollar traders seem to be betting that way. The greenback (<a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a> <font color='red'>-0.2%</font>) continues its steep 2017 downtrend, now returning<a href=\"http://finviz.com/futures_charts.ashx?t=DX&amp;p=w1\" target=\"_blank\"> to levels seen</a> early last summer.</li><li>At or near multi-year highs vs. the dollar: The euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>), loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>), swissie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXF' title='CurrencyShares Swiss Franc Trust ETF'>FXF</a>), and aussie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXA' title='CurrencyShares Australian Dollar Trust ETF'>FXA</a>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a>, <a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>, <a href='https://seekingalpha.com/symbol/EUO' title='ProShares UltraShort Euro ETF'>EUO</a>, <a href='https://seekingalpha.com/symbol/FXA' title='CurrencyShares Australian Dollar Trust ETF'>FXA</a>, <a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>, <a href='https://seekingalpha.com/symbol/UDN' title='PowerShares DB USD Bear ETF'>UDN</a>, <a href='https://seekingalpha.com/symbol/FXF' title='CurrencyShares Swiss Franc Trust ETF'>FXF</a>, <a href='https://seekingalpha.com/symbol/ERO' title='iPath EUR/USD Exchange Rate ETN'>ERO</a>, <a href='https://seekingalpha.com/symbol/USDU' title='WisdomTree Bloomberg U.S. Dollar Bullish ETF'>USDU</a>, <a href='https://seekingalpha.com/symbol/DRR' title='Market Vectors Double Short Euro ETN'>DRR</a>, <a href='https://seekingalpha.com/symbol/ULE' title='ProShares Ultra Euro ETF'>ULE</a>, <a href='https://seekingalpha.com/symbol/CROC' title='ProShares UltraShort Australian Dollar ETF'>CROC</a>, <a href='https://seekingalpha.com/symbol/EUFX' title='ProShares Short Euro ETF'>EUFX</a>, <a href='https://seekingalpha.com/symbol/URR' title='Market Vectors Double Long Euro ETN'>URR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3280981\" data-linked=\"Dollar continues to fade as FOMC begins two-day meeting\" data-tweet=\"$UUP $FXE $FXC - Dollar continues to fade as FOMC begins two-day meeting https://seekingalpha.com/news/3280981-dollar-continues-to-fade-fomc-begins-two-day-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3280981-dollar-continues-to-fade-fomc-begins-two-day-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280980\" data-ts=\"1500992748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280980-caterpillar-scope-for-2018-eps-upside-goldman-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar has scope for further 2018 EPS upside, Goldman analyst says</a></h4><ul>     <li>Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+4.4%</font>) leads early Dow gainers following its strong Q2 earnings beat and guidance bump, and Goldman Sachs analyst Jerry Revich thinks the stock has more room to run.</li>     <li>CAT&rsquo;s dealer inventories and incentive compensation suggest significant scope for further 2018 EPS upside, Revich says as he reiterates a Buy rating as part of the firm's Conviction Buy List.</li>     <li>J.P. Morgan's Ann Duignan calls the results a solid beat and raise even as expectations were high coming into the quarter.</li>     <li>Jefferies analyst Stephen Volkmann says \"CAT is in the cycle sweet spot, demonstrating massive leverage as the cycle normalizes and revenues return faster than costs, [but] the question is sustainability, both as comparisons get tougher and as costs begin to trickle back in to the model.\"</li>     <li>Also, Jim Cramer says CAT's report was the \"<a href=\"http://www.cnbc.com/2017/07/25/cramer-says-caterpillar-is-the-most-serious-beat-and-raise-of-the-earnings-season.html\" target=\"_blank\">most serious beat and raise</a> of the earnings season\" and the stock will continue to climb.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280980\" data-linked=\"Caterpillar has scope for further 2018 EPS upside, Goldman analyst says\" data-tweet=\"$CAT - Caterpillar has scope for further 2018 EPS upside, Goldman analyst says https://seekingalpha.com/news/3280980-caterpillar-scope-for-2018-eps-upside-goldman-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3280980-caterpillar-scope-for-2018-eps-upside-goldman-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280964\" data-ts=\"1500990968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280964-interpublic-groupminus-10_2-results-miss-low-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpublic Group -10.2% as results miss low estimates</a></h4><ul>   <li>Ad giant Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) is <font color='red'>off 10.2%</font> after a <a href=\"https://seekingalpha.com/news/3280843-interpublic-group-companies-misses-0_07-misses-revenue\" target=\"_blank\">rough miss</a> in its Q2 earnings, as foreign exchange and divestitures took out a modest organic revenue gain.</li>    <li>\"Client spending in the quarter reflected increased caution, but we don't see evidence of a broad-based economic downturn,\" said CEO Michael Roth.</li>    <li>Revenues fell 1.7% for the quarter, hit by a foreign exchange negative impact of 1.1% and negative impact from net divestitures of 1%. That left an organic increase of 0.4%, made up of organic gains of 0.7% in the U.S. and no organic change internationally.</li>    <li>Operating expenses declined 0.9% in Q2; they were down 0.3% for the first half of 2017. Operating income fell to $206.5M from a year-ago $224.3M. Operating margin was 11% vs. a year-ago 11.7%.</li>    <li>Cash, equivalents and marketable securities came to $660.8M at quarter's end, down from a year-ago $675.4M and $1.1B at year-end 2016. Total debt was $1.82B.</li>    <li><a href=\"http://www.interpublic.com/news/pressreleases?release_id=2288448\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3280964\" data-linked=\"Interpublic Group -10.2% as results miss low estimates\" data-tweet=\"$IPG - Interpublic Group -10.2% as results miss low estimates https://seekingalpha.com/news/3280964-interpublic-groupminus-10_2-results-miss-low-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3280964-interpublic-groupminus-10_2-results-miss-low-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280959\" data-ts=\"1500990888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RETA\" target=\"_blank\">RETA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280959-reata-up-2-after-citi-bumps-price-target-to-87\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reata up 2% after Citi bumps price target to $87</a></h4><ul><li>Reata Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='green'>+1.6%</font>) adds modestly to yesterday's 14% spike after the company reported positive Phase 2 results on bardoxolone.</li><li>Citigroup has jumped on the bullish bandwagon with an upward price target revision to $87 (145% upside) from $39.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280574-reatas-bardoxolone-methyl-shows-treatment-effect-mid-stage-kidney-disease-study-shares-ahead\" target=\"_blank\">Reata's bardoxolone methyl shows treatment effect in mid-stage kidney disease study; shares ahead 20%</a> (July 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3280959\" data-linked=\"Reata up 2% after Citi bumps price target to $87\" data-tweet=\"$RETA - Reata up 2% after Citi bumps price target to $87 https://seekingalpha.com/news/3280959-reata-up-2-after-citi-bumps-price-target-to-87?source=tweet\" data-url=\"https://seekingalpha.com/news/3280959-reata-up-2-after-citi-bumps-price-target-to-87\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280958\" data-ts=\"1500990571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABG\" target=\"_blank\">ABG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280958-on-asbury-automotive-groups-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Asbury Automotive Group&#39;s Q2</a></h4><ul>     <li>Asbury Automotive Group (<a href='https://seekingalpha.com/symbol/ABG' title='Asbury Automotive Group, Inc.'>ABG</a> <font color='red'>-6.8%</font>)&nbsp;reports total revenues on same-store basis rose 2% in <a href=\"https://seekingalpha.com/pr/16894975-asbury-automotive-group-announces-second-quarter-2017-financial-results\" target=\"_blank\">Q2</a>.</li>     <li>New vehicles revenue up 2% to $882.9M.</li>     <li>Used vehicles revenue grew 2% to $479.2M.</li>     <li>Parts and service revenue expanded 3% to $200.8M.</li>     <li>Finance and insurance, net revenue increased 6% to $68.9M.</li>     <li>Gross margin rate flat at 16.4%.</li>     <li>Adjusted operating margin rate down 30 bps to 4.5%.</li>     <li>Total new vehicle unit sales slipped 2% Y/Y to 25,131M.</li>     <li>Total used vehicle retail units sales +3% to 20,263M.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3280958\" data-linked=\"More on Asbury Automotive Group&#39;s Q2\" data-tweet=\"$ABG - More on Asbury Automotive Group&#39;s Q2 https://seekingalpha.com/news/3280958-on-asbury-automotive-groups-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3280958-on-asbury-automotive-groups-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280955\" data-ts=\"1500990109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280955-on-supervalus-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Supervalu&#39;s Q1 results</a></h4><ul>     <li>Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='green'>+4%</font>)&nbsp;reports Wholesale net sales rose 12.4% to $2.56B in <a href=\"https://seekingalpha.com/pr/16894912-supervalu-reports-first-quarter-fiscal-2018-results\" target=\"_blank\">Q1</a>,&nbsp;primarily due to sales to new customers and increased sales to new stores operated by existing customers.</li>     <li>Retail net sales squeezed 2.7% to $1.39B and identical store sales down 4.9%.</li>     <li>Gross margin rate fell 80 bps to 13.8% primarily due to the change in business segment mix, with Wholesale representing a larger portion of total sales and gross profit.</li>     <li>Adjusted SG&amp;A expense rate improved 50 bps to 11.8%.</li>     <li>Operating margin rate declined 70 bps to 1.7%.</li>     <li><b>FY2018 Guidance</b>: Net earnings from continuing operations: $51M to $70M; Adjusted EBITDA: $475M to $495M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280955\" data-linked=\"More on Supervalu&#39;s Q1 results\" data-tweet=\"$SVU - More on Supervalu&#39;s Q1 results https://seekingalpha.com/news/3280955-on-supervalus-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3280955-on-supervalus-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280954\" data-ts=\"1500989977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKS\" target=\"_blank\">AKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280954-ak-steel-opensplus-7-after-big-q2-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AK Steel opens +7% after big Q2 earnings beat</a></h4><ul>     <li>AK&nbsp;Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+7.7%</font>) surges at the open after easily beating <a href=\"https://seekingalpha.com/news/3280912-ak-steel-beats-0_07-beats-revenue\" target=\"_blank\">Q2 earnings</a> estimates, saying its strong performance highlights continued benefits achieved through strategic initiatives it implemented during the past year and a half.</li>     <li>AKS says Q2 shipments declined 6% Y/Y to 1.46M tons mainly resulting from a decrease in automotive demand, but the average selling price jumped 11% Y/Y to $1,058/ton from $957,  primarily due to a higher average selling price on both contract  and spot market sales and higher surcharges on specialty steel products.</li><li>Other steel names are running higher, with <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+4%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+2.5%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+2.9%</font>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+3.4%</font>; another possible catalyst for the steel sector is the Section 232 decision, which could  be announced today when Pres. Trump holds a rally in Youngstown, Ohio.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280954\" data-linked=\"AK Steel opens +7% after big Q2 earnings beat\" data-tweet=\"$AKS $AKS $X - AK Steel opens +7% after big Q2 earnings beat https://seekingalpha.com/news/3280954-ak-steel-opensplus-7-after-big-q2-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3280954-ak-steel-opensplus-7-after-big-q2-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280953\" data-ts=\"1500989626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COT\" target=\"_blank\">COT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280953-cott-flies-after-asset-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cott flies after asset sale</a></h4><ul> <li>Cott (NYSE:<a href='https://seekingalpha.com/symbol/COT' title='Cott Corporation'>COT</a>) rallies after pulling off a deal to sell its bottling activities for $1.25B.</li> <li>Shares opened trading <font color='green'>up 9.30%</font> to hit their highest level of 2017.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3280849-cott-sells-beverage-manufacturing-business-refresco\" target=\"_blank\">Cott sells beverage manufacturing business to Refresco</a> (July 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280953\" data-linked=\"Cott flies after asset sale\" data-tweet=\"$COT - Cott flies after asset sale https://seekingalpha.com/news/3280953-cott-flies-after-asset-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3280953-cott-flies-after-asset-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280950\" data-ts=\"1500989240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280950-neuralstems-nsiminus-189-flunks-mid-stage-study-in-mdd-shares-plummet-61-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem&#39;s NSI-189 flunks mid-stage study in MDD; shares plummet 61% premarket</a></h4><ul><li>Thinly traded nano cap Neuralstem (NYSEMKT:<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a>) craters&nbsp;<font color='red'>61%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16895273-neuralstem-announces-top-line-phase-2-data-nsiminus-189-major-depressive-disorder\" target=\"_blank\">announcement</a> that NSI-189 failed to demonstrate a treatment benefit in a Phase 2 clinical trial in patients with major depressive disorder &#40;MDD&#41;.</li><li>Specifically, treatment with NSI-189 failed to show a significant reduction in depression symptoms as measured by a scale called MADRS.</li><li>One ray of hope is a secondary endpoint of a patient-rated scale of depression called SDQ (Symptoms of Depression Questionnaire). The 40 mg once-daily dose cohort achieved statistical significance (p=0.044) versus placebo.</li><li>According to the company, small molecule NSI-189 stimulates neurogenesis, synaptogenesis and increases hippocampal volume, all of which play a role in reversing depression, enhancing cognition and promoting the growth of new nerve tissue.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268526-neuralstem-completes-dosing-mid-stage-study-nsiminus-189-mdd-shares-ahead-6-percent\" target=\"_blank\">Neuralstem completes dosing in mid-stage study of NSI-189 in MDD; shares ahead 6%</a> (May 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3280950\" data-linked=\"Neuralstem&#39;s NSI-189 flunks mid-stage study in MDD; shares plummet 61% premarket\" data-tweet=\"$CUR $SNCA - Neuralstem&#39;s NSI-189 flunks mid-stage study in MDD; shares plummet 61% premarket https://seekingalpha.com/news/3280950-neuralstems-nsiminus-189-flunks-mid-stage-study-in-mdd-shares-plummet-61-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3280950-neuralstems-nsiminus-189-flunks-mid-stage-study-in-mdd-shares-plummet-61-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280948\" data-ts=\"1500989110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEM\" target=\"_blank\">NEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280948-newmont-mining-posts-strong-q2-beat-production-jumps-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Newmont Mining posts strong Q2 beat, production jumps 13%</a></h4><ul>     <li>Newmont Mining (NYSE:<a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a>) <font color='green'>+1.7%</font> premarket after routing <a href=\"https://seekingalpha.com/news/3280890-newmont-mining-beats-0_20-beats-revenue\" target=\"_blank\">Q2 earnings</a> expectations as revenues rose 12% Y/Y and <a href=\"http://www.reuters.com/article/us-newmont-mining-results-idUSKBN1AA1FU\" target=\"_blank\">production improved</a>, more than offsetting losses from slightly lower realized gold prices.</li>     <li>NEM says Q2 attributable gold production gained 13% to 1.4M oz., as new production from Merian and Long Canyon more than offset lower grades at Tanami and Yanacocha; gold CAS was $664/oz. vs. $661 in the prior-year quarter, and gold AISC was $884/oz. compared to $913 a year ago, primarily due to lower sustaining capital and higher sales volumes.</li>     <li>NEM ended Q2 with $3.1B in cash on hand, a leverage ratio of 0.6x net debt to adjusted EBITDA and one of the best credit ratings in the mining sector</li>     <li>For FY 2017, NEM forecasts improved attributable gold production of 5M-5.4M oz., as full-year production at Merian and Long Canyon more than offset declines at Twin Creeks and Yanacocha; 2018 production guidance is unchanged at 4.7M-5.2M oz.</li>     <li>FY 2017 CAS guidance improves to $675-$715/oz., AISC guidance improves to $900-$950/oz., and capex guidance is lowered to $890M-$990M; capex guidance for 2018 is unchanged at $900M-$1B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280948\" data-linked=\"Newmont Mining posts strong Q2 beat, production jumps 13%\" data-tweet=\"$NEM - Newmont Mining posts strong Q2 beat, production jumps 13% https://seekingalpha.com/news/3280948-newmont-mining-posts-strong-q2-beat-production-jumps-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3280948-newmont-mining-posts-strong-q2-beat-production-jumps-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280946\" data-ts=\"1500988938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLKS\" target=\"_blank\">FLKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280946-flex-pharmas-flxminus-787-fast-trackd-in-u-s-for-als-related-muscle-cramps-shares-ahead-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flex Pharma&#39;s FLX-787 Fast Track&#39;d in U.S. for ALS-related muscle cramps; shares ahead 9% premarket</a></h4><ul><li>Thinly traded nano cap Flex Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/16895023-fda-grants-fast-track-designation-flex-pharma-s-flxminus-787-treatment-severe-muscle-cramps\" target=\"_blank\">announcement </a>that the FDA has designated FLX-787 for Fast Track review for the treatment of muscle cramps associated with amyotrophic lateral sclerosis &#40;ALS&#41;. A Phase 2 study should commence this quarter.</li><li>Fast Track status provides for more frequent interactions with the FDA review team and a rolling review of the New Drug Application.</li><li>The company describes FLX-787 as a&nbsp;<a href=\"https://en.wikipedia.org/wiki/Transient_receptor_potential_channel\" target=\"_blank\">transient receptor potential ion channel</a>&nbsp;activator, specifically a co-activator of the proteins TRPA1 and TRPV1.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259954-fda-oks-flex-pharmas-ind-als-candidate-flxminus-787-phase-2-study-tap-summer\" target=\"_blank\">FDA OK's Flex Pharma's IND for ALS candidate FLX-787; Phase 2 study on tap for summer</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3280946\" data-linked=\"Flex Pharma&#39;s FLX-787 Fast Track&#39;d in U.S. for ALS-related muscle cramps; shares ahead 9% premarket\" data-tweet=\"$FLKS $SLRX - Flex Pharma&#39;s FLX-787 Fast Track&#39;d in U.S. for ALS-related muscle cramps; shares ahead 9% premarket https://seekingalpha.com/news/3280946-flex-pharmas-flxminus-787-fast-trackd-in-u-s-for-als-related-muscle-cramps-shares-ahead-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3280946-flex-pharmas-flxminus-787-fast-trackd-in-u-s-for-als-related-muscle-cramps-shares-ahead-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280945\" data-ts=\"1500988520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280945-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-62%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16895273-neuralstem-announces-top-line-phase-2-data-nsiminus-189-major-depressive-disorder\" target=\"_blank\">announcing</a> top-line Phase 2 data of NSI-189 for major depresssive disorder.</li><li><a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a>&nbsp;<font color='red'>-19%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3280896-seagate-technology-misses-0_34-misses-revenue\" target=\"_blank\">Q4 earnings</a> miss.</li><li><a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>&nbsp;<font color='red'>-18%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16894547-novavax-announces-positive-topline-data-phase-2-older-adult-trial-provides-path-forward-rsv-f\" target=\"_blank\">announcing</a> top-line data from Phase 2 older adult trial.</li><li><a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3280908-paciras-pain-med-exparel-shows-mixed-results-two-late-stage-studies-shares-slip-7-percent\" target=\"_blank\">announcing</a> results from two Phase 3 clinical trial evaluating EXPAREL for prolonged regional pain relief.</li><li><a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3280843-interpublic-group-companies-misses-0_07-misses-revenue\" target=\"_blank\">Q2 earnings miss</a>.</li><li><a href='https://seekingalpha.com/symbol/FTI' title='TechnipFMC plc'>FTI</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3280750-technipfmc-restate-q1-overstating-net-income\" target=\"_blank\">announcing</a> restatement of Q1 financial statements.</li><li><a href='https://seekingalpha.com/symbol/LOGI' title='Logitech International S.A.'>LOGI</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3280762-logitech-reports-q1-result-ups-guidance\" target=\"_blank\">Q1 result</a>.</li><li><a href='https://seekingalpha.com/symbol/TEAR' title='TearLab Corporation'>TEAR</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3280945\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$SNCA $STX $NVAX - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3280945-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3280945-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280942\" data-ts=\"1500988325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280942-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='green'>+13%</font>&nbsp;after Sandell Asset Management takes <a href=\"https://seekingalpha.com/news/3280854-activist-investor-thinks-barnes-and-noble-worth-billion\" target=\"_blank\">stake</a>.</li>     <li><a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a> <font color='green'>+9%.</font></li>     <li><a href='https://seekingalpha.com/symbol/MDCO' title='The Medicines Company'>MDCO</a> <font color='green'>+7%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3280892-late-stage-study-medicines-cos-antibiotic-combo-vabomere-stopped-early-u-s-approval-likely\" target=\"_blank\">announcement</a>&nbsp;on its Phase 3 clinical trial,&nbsp;TANGO-2.</li>     <li><a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+6%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3280912-ak-steel-beats-0_07-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+5%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3280862-caterpillar-beats-0_23-beats-revenue\" target=\"_blank\">result</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280942\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$BKS $GNCA $MDCO - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3280942-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3280942-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280940\" data-ts=\"1500988208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280940-enteromedics-up-4-premarket-on-first-vbloc-implant-dallas-hospital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnteroMedics up 4% premarket on first vBloc implant at Dallas hospital</a></h4><ul><li>Nano cap EnteroMedics (ETRM) perks up&nbsp;<font color='green'>4%</font>&nbsp;premarket on light volume after it&nbsp;<a href=\"https://seekingalpha.com/pr/16894978-enteromedics-announces-first-veterans-choice-program-vbloc-implant-obesity-methodist-dallas\" target=\"_blank\">announced</a> the first implant of its vBloc Neurometabolic Therapy at the Methodist Dallas Medical Center. The procedure was provided through the Veterans Choice Program which allows veterans to have the vBloc procedure at a local facility instead of a VA hospital.</li></ul><div class=\"tiny-share-widget\" data-id=\"3280940\" data-linked=\"EnteroMedics up 4% premarket on first vBloc implant at Dallas hospital\" data-tweet=\"$RSLS - EnteroMedics up 4% premarket on first vBloc implant at Dallas hospital https://seekingalpha.com/news/3280940-enteromedics-up-4-premarket-on-first-vbloc-implant-dallas-hospital?source=tweet\" data-url=\"https://seekingalpha.com/news/3280940-enteromedics-up-4-premarket-on-first-vbloc-implant-dallas-hospital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280935\" data-ts=\"1500987873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280935-acelrx-pharma-poised-to-continue-up-move-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AcelRx Pharma poised to continue up move; shares ahead 7% premarket</a></h4><ul><li>Micro cap AcelRx Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>) is up&nbsp;<font color='green'>7%&nbsp;</font>premarket on increased volume. Shares have almost doubled since early July. No particular company news accounts for the action, although Jefferies did its part by initiating coverage on the 14th with a Buy rating and $7 price target.</li><li>The company's U.S. marketing application for pain med DSUVIA is currently under FDA review with an action date of October 12.</li><li>It is due to <a href=\"https://seekingalpha.com/pr/16894610-acelrx-pharmaceuticals-hold-second-quarter-2017-financial-results-conference-call-webcast\" target=\"_blank\">report </a>Q2 results after the close on Wednesday, August 2. Consensus view is a loss/share of ($0.28) on revenue of $2.3M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3280935\" data-linked=\"AcelRx Pharma poised to continue up move; shares ahead 7% premarket\" data-tweet=\"$ACRX - AcelRx Pharma poised to continue up move; shares ahead 7% premarket https://seekingalpha.com/news/3280935-acelrx-pharma-poised-to-continue-up-move-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3280935-acelrx-pharma-poised-to-continue-up-move-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280927\" data-ts=\"1500987551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280927-mcdermottminus-9-after-missing-on-q1-earnings-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott -9% after missing on Q1 earnings, revenues</a></h4><ul>     <li>McDermott (NYSE:<a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a>) <font color='red'>-9.1%</font> premarket after <a href=\"https://seekingalpha.com/news/3280880-mcdermott-misses-0_01-misses-revenue\" target=\"_blank\">Q2 earnings</a> slightly miss Wall Street estimates and revenues come in 10% short of expectations.</li>     <li>MDR says its backlog at the end of Q2 was $3.3B, compared to $3.9B at the end of Q1; of the June 30 backlog, ~85% was related to offshore operations and 15% was related to subsea operations.</li>     <li>Q2 order intake totaled $188M, resulting in a book-to-bill ratio of 0.2x.</li>     <li>MDR says it has $1.4B bids and change orders outstanding and $15.4B in identified target projects in its pipeline that it expect will be awarded in the market through Q3 2018.</li>     <li>Reaffirms FY 2017 EPS guidance of ~$0.42 vs. $0.41 analyst consensus estimate and sees revenues of $3.2B vs. $3.19B consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3280927\" data-linked=\"McDermott -9% after missing on Q1 earnings, revenues\" data-tweet=\"$MDR - McDermott -9% after missing on Q1 earnings, revenues https://seekingalpha.com/news/3280927-mcdermottminus-9-after-missing-on-q1-earnings-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3280927-mcdermottminus-9-after-missing-on-q1-earnings-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280926\" data-ts=\"1500987549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNC\" target=\"_blank\">CNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280926-centene-q2-revenues-up-10-earnings-up-49-shares-ahead-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centene Q2 revenues up 10%; earnings up 49%; shares ahead 5% premarket</a></h4><ul><li>Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>) <a href=\"https://seekingalpha.com/pr/16894883-centene-corporation-reports-2017-second-quarter-results-and-raises-2017-guidance\" target=\"_blank\">Q2 results</a>: Revenues: $11,954M (+9.7%); Operating Income: $438M (+16.2%); Net Income: $254M (+49.4%); EPS: $1.44 (+46.9%); Non-GAAP EPS: $1.59 (+23.3%); Quick Assets: $5,011M (+13.0%); CF Ops: $942M.</li><li><strong>2017 Guidance</strong>: Total Revenues: $46.4B - 47.2B; EPS: $3.96 - 4.29; Non-GAAP EPS: $4.70 - 5.06; Health benefits ratio: 87.0 - 87.4%.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3280926\" data-linked=\"Centene Q2 revenues up 10%; earnings up 49%; shares ahead 5% premarket\" data-tweet=\"$CNC - Centene Q2 revenues up 10%; earnings up 49%; shares ahead 5% premarket https://seekingalpha.com/news/3280926-centene-q2-revenues-up-10-earnings-up-49-shares-ahead-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3280926-centene-q2-revenues-up-10-earnings-up-49-shares-ahead-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280922\" data-ts=\"1500987217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCA\" target=\"_blank\">HCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280922-hca-q2-top-line-up-4-earnings-flat-cash-flow-down-2-shares-down-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HCA Q2 top line up 4%; earnings flat; cash flow down 2%; shares down 5% premarket</a></h4><ul><li>HCA Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a>) <a href=\"https://seekingalpha.com/pr/16895289-hca-reports-second-quarter-2017-results\" target=\"_blank\">Q2 results</a> ($M): Revenues: 10,733 (+4.0%).</li><li>Net Income: 657 (-0.2%); EPS: 1.75 (+6.1%) CF Ops (6 mo.): 2,684 (-2.3%).</li><li>Same facility revenue/equivalent admission up 2.0%. Same facility admissions up 0.8%.</li><li><strong>2017 Guidance</strong>: Revenues: $43.0B - 44.0B; EPS: $7.00 - 7.30; Non-GAAP EBITDA: $8.35B - 8.50B; Capex: ~$2.9B.</li><li>Shares are down&nbsp;<font color='red'>5%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3280913-hca-holdings-misses-0_08-misses-revenue\" target=\"_blank\">HCA Holdings misses by $0.08, misses on revenue</a> (July 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3280922\" data-linked=\"HCA Q2 top line up 4%; earnings flat; cash flow down 2%; shares down 5% premarket\" data-tweet=\"$HCA - HCA Q2 top line up 4%; earnings flat; cash flow down 2%; shares down 5% premarket https://seekingalpha.com/news/3280922-hca-q2-top-line-up-4-earnings-flat-cash-flow-down-2-shares-down-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3280922-hca-q2-top-line-up-4-earnings-flat-cash-flow-down-2-shares-down-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3280917\" data-ts=\"1500986631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYRX\" target=\"_blank\">CYRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3280917-cryoport-inks-deal-novartis-for-logistics-support-of-car-ts-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CryoPort inks deal with Novartis for logistics support of CAR-Ts; shares ahead 7% premarket</a></h4><ul><li>CryoPort (NASDAQ:<a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16894944-cryoport-support-launch-potential-treatment-relapsed-refractory-acute-lymphoblastic-leukemia\" target=\"_blank\">announcement </a>that it has inked a three-year agreement with Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) for cryogenic logistics support for CTL019/CD19 CAR-T cell therapy.</li><li>The company says its support will include the use of its Cryoport Express shippers, SmartPak II Condition Monitoring System, Cryoportal Logistics Management Platform (chain-of-condition and chain-of-custody monitoring) and around-the-clock logistics support.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3280917\" data-linked=\"CryoPort inks deal with Novartis for logistics support of CAR-Ts; shares ahead 7% premarket\" data-tweet=\"$CYRX $CYRX $NVS - CryoPort inks deal with Novartis for logistics support of CAR-Ts; shares ahead 7% premarket https://seekingalpha.com/news/3280917-cryoport-inks-deal-novartis-for-logistics-support-of-car-ts-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3280917-cryoport-inks-deal-novartis-for-logistics-support-of-car-ts-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}